¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/5/1 ¤U¤È 10:31:55
²Ä 3719 ½g¦^À³
|
§@®a§d²H¦p:´I¦³¬O¤@ºØ¿ï¾Ü¡A¦Ó³o¹Lµ{n¾a§Aªº°í«ù¡C½a°¤£·Q°Ê¸£¡A¥u·Q¤£³Ò¦ÓÀò¡C §ë¸ê·sÃĥͧÞÁÙ¬OÃöª`¦b¨ä¦¨¥\²v»PÃÄ«~¥«³õ¡C ¤µ¤Ñ³o®a¤½¥q¦b¥²´Iºô³Ì°ª¶R»ù203(Á`¸g²zµ¥¤HÂ÷¾¤]°í«ù¦í¨S¥þ³¡½æ±¼¡A10¦~§ë¸êÀò§Q>30¿¡Aµ¥~100¿¤H¨ú§Ú±ó) ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/12/28 ¤U¤È 05:11:17²Ä 31 ½g¦^À³ ¥ý®¥³ß7¦~«e±µ¤â«¥½æªÑªº§ë¸ê¤H... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:38:46²Ä 1919 ½g¦^À³ ¤µ¤Ñ¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù128~129¡A½æ»ù150¡C ....9¦~«e«Ü¦h¤H¥ÎÁ«·l»ù½æ¥X¡A«Ü¦nij»ù¦b¤Q¶ôªì¦¨¥æ¡C ·|§ë¸ê³o®a¤½¥q¬Oª¾¹D¨ä²£«~ªùÂe·¥°ª(¥xÆW«ÜÃø¦A¦³²Ä2®a¥X²{)¡C (¿ù»~)ªº¨M©w---³o¬O±q¤µ¤ÑªºÀò§Q»PªÑ»ùµ²ªG¨Ó¬Ý¡A¦ý¦b·í®É¬O(¹ï)ªº¨M©w¡A¦]¬°¨S¦h¤[¶Ç¥XÁ`¸g²zµ¥¤HÂ÷¾... --------------------------------------------------------------------------------------------- ...¦pªG¤£¬O5¦~«e»P¤@¦ì¬ãµo¸g²z²á¤Ñ«á³B²zX«ùªÑ(¿ù»~ªº¨M©w)¡A²{¦b¤â¤WX±i¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/5/1 ¤U¤È 10:03:42
²Ä 3718 ½g¦^À³
|
§Ú̺¦¸ÃÒ©ú¤T´â½©¿}«æ¼@¼W¥[²É½uÅé¥Íª«¯à¡A¨ä¯S¼x¬O¯Ó®ñ¶q©M¸ó½¤¹q¦ì[¼W¥[]---¹q¦ì¹L°ª»P¹L§C³£·|¥X²{¤ò¯f.
2020.11.23-µoª¢©M§Üµoª¢Àô¹Ò¹ï¥¨¾½²ÓM²É½uÅé¥\¯àªº¼vÅT www.nature.com/articles/s41598-020-77370-x ..LPS ¨ë¿E«á¡AÃöÁä TCA 酶ªºªí¹F¥H¤Î ²É½uÅ齤¹q¦ì[°§C]¡A¦Ó LC3b ©M ROS ¤ô¥¤É°ª¡C ..§Ú̪ºµ²ªGÁÙªí©ú¡A¸g¹L LPS ³B²z¡AROS ©M¦Û¾½§@¥Î¼W¥[¡A¦Ó²É½uÅ齤¹q¦ì[¤U°]...¦¹¥~¡A²É½uÅ齤¹q¦ìªº°§Cªí©ú ²É½uÅé¥\¯à¨ü¨ìt±¼vÅT¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/31 ¤U¤È 09:47:51²Ä 3642 ½g¦^À³ MOA of SNP-630 and SNP-610 in NASH SNP-6 can tackle multiple pathways impacting the pathogenesis of NASH1, ¼g¤JLPS-TLR4?
----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/6 ¤U¤È 09:38:20²Ä 3611 ½g¦^À³ 2017-¤T´â½©¿}´î®z LPS(¸z¹D²Óµß²£ª«)¤¶¾ÉªºHSP27°T¸¹ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/5/1 ¤U¤È 08:06:14
²Ä 3717 ½g¦^À³
|
²É½uÅé²¾´ÓÀøªk! ¦pªG§âÀù²ÓMªº²ÓM®Ö¡]¸Ì±§t¦³¬ðÅܪºDNA¡^ª`¤J¥¿±`²ÓM¤¤¡A½Ð°Ý¡A¨ºÓ¥¿±`²ÓM¤Àµõ¤§«á¡A·|Åܦ¨Àù²ÓMÁÙ¬O¥¿±`²ÓM¡H
1.2018.7.12-²É½uÅé²¾´Ó·sÀøªk ««¦º¤ßŦ¸¡¥Í ¬ü°êªi¤h¹y¨àµ£Âå°|ªºÂå¥Í§Q¥Î²É½uÅé²¾´ÓÀøªk¡AÀ°§U««¦º¾¹©x«ì´_¥\¯à¡Iªi¤h¹y¤@¦W¤kÀ¦¡A¦]¥ý¤Ñ©Ê¤ßŦ¯f³y¦¨¤ß¸õÆJ °±¡A¤ß¦Ù¦]¯Ê®ñ¹L¤[¦ÓÃa¦º¡A¦bµLp¥i¬Iªº±¡ªp¤U¡AÂåÀø¹Î¶¤¹Á¸Õ±N¤kÀ¦¦Û¨ªº [²É¸¢Åé] ª`¤J¦oªº¤ßŦ¡A¦¨¥\«ì´_¤ß Ŧ...
2.2024.4.9- ¤@ÓÄAÂÐÆ[©ÀªºÀù²ÓM¹êÅç(Àù²ÓMªº²É½uÅé³£¨ü·l) cancer.commonhealth.com.tw/article/1175 ...¦b¦¹¡A½Ð¤j®a¬Ý¤@Ó¨¬¥HÄAÂйL¥hÆ[©Àªº¹êÅç¡C°ö¾i¥×¤W¦³¨âÓ²ÓM¡A¤@Ó¬O¥¿±`²ÓM¡A¤@Ó¬OÀù²ÓM¡A¦pªG§âÀù²ÓM ªº²ÓM®Ö¡]¸Ì±§t¦³¬ðÅܪºDNA¡^ª`¤J¥¿±`²ÓM¤¤¡A½Ð°Ý¡A¨ºÓ¥¿±`²ÓM¤Àµõ¤§«á¡A·|Åܦ¨Àù²ÓMÁÙ¬O¥¿±`²ÓM¡H ... Àù¯g¨Ã«D°ò¦]¯e¯f¡A¦Ó¬O¥NÁ¯e¯f³oÓ«nªºÆ[©À§i¶D§ÚÌ¡AÀù¯g¨Ã«D¡u°ò¦]¯e¯f¡v¡A¦Ó¬O¡u¥NÁ¯e¯f¡v¡C ¥Ëº¸³ù(¥L¬O©M·R¦]´µ©Z¦P®É¥N¥B¦P¼Ë³»¦yªº¬ì¾Ç®a¡A¹ïÀù²ÓMªº¥NÁ¦³³z¹ýªº¬ã¨s¡A¨Ã¦b 1931 ¦~±o¨ì¿Õ¨©º¸¼ú)»{¬°¡A¥¿ ±`²ÓMªº¯à¶q¨Ó·½¬O²É½uÅ骺¦³®ñ©I§l¡A²£ª«¬O¤G®ñ¤ÆºÒ©M¤ô¡F¦Ó¸~½F²ÓM¥Íªøªº¯à¶q¨Ó·½¬O¡AÂǥѸ²µå¿}¦b²ÓM½è¤ºµo»Ã ¦¨ªº¨Å»Ä..
3.2022.10.22-²É½uÅé²¾´Ó¡GªvÀøªÎD¡B¿}§¿¯f©M«D°sºë©Ê¯×ªÕ¨xªº¾÷·|©M¬D¾Ô(NAFLD ³Q»{¬°¬O¤@ºØ²É½uÅé¯e¯f) translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03693-0 ...µo²{ªí©ú²É½uÅé¹v¦VÃĪ«¥i¯à¹ï NAFLD ±wªÌ²£¥Í«n¼vÅT¡C -----------------------------------------------------------------------------------------
4. 2021.1.18-¤T´â½©¿}¨ë¿E Caco-2 ²ÓM¤¤ªº²É½uÅé¥Íª«¯à §Ú̺¦¸ÃÒ©ú¤T´â½©¿}«æ¼@¼W¥[²É½uÅé¥Íª«¯à¡A¨ä¯S¼x¬O¯Ó®ñ¶q©M¸ó½¤¹q¦ì¼W¥[...
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/5/1 ¤W¤È 10:28:01
²Ä 3716 ½g¦^À³
|
¤j®a³£¦³§ë¸ê¡A¥u¬O¤£¦p¹w´Á ¥ý¤£»¡skd¨S¶i®i(Àt³t)¡A»æ¤Sµe¤j¡C ¤@¦~©ì¤@¦~¡C ªÑ»ù½ß¤F¤S®ö¶O«C¬K¡C¤@¨ý¬Ý¦n¦ýªÑ»ù»¡¸Ü¡A¤£n·d±o©M¤ß®®¤@¼Ë
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/30 ¤W¤È 11:15:57
²Ä 3715 ½g¦^À³
|
³o¸Ì¤£¬O¤@¨¥°ó¡A¯u¤ßÅwªï´£¥X¬ì¾Ç¼Æ¾Ú¤Ï»é¡A¤£§@¤H¨·´Á½§ðÀ»! |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/30 ¤W¤È 11:11:47
²Ä 3714 ½g¦^À³
|
·|û¡GCrest10153652 µoªí®É¶¡:2024/4/29 ¤W¤È 12:36:56²Ä 3711 ½g¦^À³ 没ú«没Õuªº¥Î数¦r乱«÷乱ú¤´N来½k§Ë¤@³q, 该说§A¬O°ä烂¤j师还¬Oºâ©R¤j¥P©O? ----------------------------------------------------------------------------------
¾Dªù®{½|¡u°äÄ꯫¡v ¨È¬w¨®¯«Àò§P40¸U©wù©
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GCrest10153652 |
µoªí®É¶¡:2024/4/29 ¤W¤È 10:52:54
²Ä 3713 ½g¦^À³
|
¥ÎÓ¡H¨Ó¨ø³d¡Aì¨Ó¬O³o¼Ë¡I ¬JµM¤£´±t³d¡A¦ó¥²ÁÙµo¤å¡H - - ¥Î²Åé¦r´N°ê¯»¡H §An¤£n¬Ý¬Ý§A¦Û¤v¥Î¤F¦h¤Ö²Åé¦r |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/29 ¤W¤È 08:06:15
²Ä 3712 ½g¦^À³
|
Á٨Ӱ꯻? ¤£µø[???]¡A5¤ë¬Ý¸³ºÊ«ùªÑ¤£´N±o¤F¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GCrest10153652 |
µoªí®É¶¡:2024/4/29 ¤W¤È 12:36:56
²Ä 3711 ½g¦^À³
|
没ú«没Õuªº¥Î数¦r乱«÷乱ú¤´N来½k§Ë¤@³q, 该说§A¬O°ä烂¤j师还¬Oºâ©R¤j¥P©O? 这ý©³£¯à§è, 该¤£会长´Á¥H来ªº贴¤å³£¬O°§è!?
-- 没证Õuªº话´N¤£¥Î¦h说¤F, 轶¨Æ?¯uªº¦³发¥Í吗?还¬O¤S来½MÙT©O? ÊI¸ô¤W³y谣¤]¬O¦³ªk«ß责¥ôªº. |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/27 ¤W¤È 11:34:33
²Ä 3710 ½g¦^À³
|
³o¶g1,000±i¥H¤W(+8±i)¡A¦¶¸³ª£ªº¾{³½¦Û¤v¦Y??? ¦³¬q¶c¨Æ¡AªYÄ£¤é«á¥¿±¦V¤W§Ú¦A»¡¡A¤Ï¤§´N¬O§¾¸Ü¨S¥²n¦AÁ¿¡I -------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/20 ¤W¤È 08:52:56²Ä 3703 ½g¦^À³ ...1,000±i¥H¤W(+11±i)¡A§C±µ400~600±i½æ¥X(-60±i¤j·§¬OÂ÷¾¥ÛªF¤¸½æ¥X?) ------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/3 ¤U¤È 09:00:02²Ä 3682 ½g¦^À³ ...ÄCÀY¦Y¤Ó¦h¡A°Æ§@¥Î¬OÀY©ü²´ªá@ ¸ê®Æ¦~¤ë¡G11303 ¸³¨Æªø¥»¤H ¦¶³Í¥Á ¿ï¥ô·í®É«ù¦³ªÑ¼Æ 1,415,500 ¤W¤ë¹ê»Ú«ù¦³ªÑ¼Æ 1,667,500 ¥»¤ë¹ê»Ú¦Û¦³«ù¦³ªÑ¼Æ1,742,000 ¥»¤ë¼W¥[74,500
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/21 ¤U¤È 05:00:34
²Ä 3709 ½g¦^À³
|
镇µh药¡A为¤°¤\会¦¨为¤U¤@个热门¡H
2023.11.29-镇µh药ªº¤d亿¥«场¡u风¤ª¡v 骎¤¦Ál 药´¼ÊI 2023-11-29 17:46 «庆 2023¦~¡A医药领°ì³Ì¥O¤H¿E动ªºÓì应¯g¬ð¯}¤Ö¤£¤FªÎD¯g¡A¤£仅诺©M诺¼wWegovyªí现¥XÕa¤Hªº¥«场¥e¦³¯à¤O¡A¦Ó¥Bþ÷来ªºZepbound¤]¦b11¤ë¥÷±o¨ì¤FFDA针对ªÎD¯gªº§åã¡C¤@时间¡AªÎD¯g药ª«¦¨为¤F医药领°ì³Ì¬z¬z乐¹Dªº话题¡A¦Ó¥B这个话题¥²将«ù续¤U¥h¡C µM¦Ó¡A°£¤Fú£ªÎ药ª«¤§¥~¡A还¦³þ个药ª«领°ì¬Oȱo医药¤H«点关ª`ªº¡Hµª®×¬O镇µh类药ª«¡C 镇µh药¡A为¤°¤\会¦¨为¤U¤@个热门¡H 镇µh药¦³¥i¯à¦¨为¤U¤@个热门赛¹D¡A¥Dn¦³¤L个¤è±ì¦]: ÆΪxªº±wªÌ»Ý¨D¡GºC©Ê¯kµh¬O¥þ²yS围内ªº¤@Ïú´¶¹M°·±d问题¡A¼v响þÓ¤j¶qªº±wªÌ¡C¥Ñ¤_¤H¤f¦Ñ龄¤Æ©MºC©Ê¯e¯fªº¼W¥[¡A对¤_¯kµhªv疗ªº»Ý¨D¤£断¤W¤É¡C
¥¼满¨¬ªº医疗»Ý¨D¡G尽ºÞ¦s¦b¦hÏú¯kµhºÞ²zªº药ª«©Mªv疗¤èªk¡A¦ý¤´¦³许¦h±wªÌ没¦³±o¨ì¦³®Äªº¯kµh缓¸Ñ¡C¦]¦¹¡A¦s¦bþÓ对§ó¦³®Ä¡B§ó¦w¥þªº¯kµhªv疗¤èªkªº¥¨¤j»Ý¨D¡C
创·s§Þ术ªº±U°_¡G随þӥͪ«§Þ术©M医学§Þ术ªº¤£断发®i¡A¯F现¥X许¦h·sªº¯kµhªv疗¤èªk¡C这¥]¬A°ò¦]ªv疗¡B¯«经调±±§Þ术¡B¥Íª«¨î剂µ¥¡A这¨Ç·s§Þ术¥i¯à为¯kµh±wªÌ´£¨Ñ§ó¦³®Ä©M©w¨îªºªv疗选择¡C
¥«场ýͤO¡G¯kµhªv疗¥«场¨ã¦³¥¨¤jªº¥«场ýͤO¡A创·sªºªv疗¤èªk©M·s«¬药ª«¥i¯à¦b¥«场¤W¨ú±o¥¨¤j¦¨¥\¡C
¬F©²关ª`¡G针对ºC©Ê¯kµh©M药ª«滥¥Î问题¡A¬F©²©M卫¥Í组织对¯kµhªv疗领°ì´£°ª¤F关ª`¡C
镇µh药ª«开发ªº«n©Ê¡A从ªü¤ù类镇µh药ªºªÀ会问题¨¤«×来¬Ý¤×为¬ð¥X¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/21 ¤U¤È 04:51:07
²Ä 3708 ½g¦^À³
|
[¯kµhÃÄ]¥«³õ¦³¼ç¤O¦¨¬°¤U¤@Ó[´î«ÃÄ]¥«³õ!!!
2023.11.28-¤G´Á临§É¼À动¦Ê亿¬üª÷¥«È¡A¤U¤@个¡§ú£ªÎ药¡¨ªº疯¨g 36kr.com/p/2563377631553158 ...¦b华ûصó¤ÀªR师¬Ý来¡A¥«场¤´严«§C¦ô¤FVX-548ªºýͤO¡A¯kµh¥«场¦³ýͤO¦¨为¤U¤@个ú£«药¥«场¡C 这¬O¦]为镇µh药ª«¥«场¥»´NÌå¨ä庞¤j¡C2022¦~¥þ²y¯kµhºÞ²z药ª«¥«场规¼Ò为770亿¬ü¤¸¡A¦Ó¦b2032¦~这¤@数¦r预计达1162亿¬ü¤¸¡C ... 从±wªÌ规¼Ò来¬Ý¡A镇µh药ª«±wªÌ¸sÊ^庞¤j¡A¤×¨ä¬O¦b¬ü国¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/21 ¤U¤È 04:36:16
²Ä 3707 ½g¦^À³
|
112¦~7¤ë31¤é¨ú±oTFDA®Öã¦P·N§ë»P¾¯¶q©ñ¤j¬°12§J(·s¼W12¤H¡A¦Xp48¤H) 112¦~11¤ë1¤é¶W¹L²{¦æ¤AñQÓi×ôÃÄ«~»¡©ú®Ñ³Ì¤j«Øij¾¯¶q¤T¿¤§Á{§É¸ÕÅ秹¦¨¦¬®× ----------------------------------------------------------------------------
113¦~1¤ë29¤é-¤½§iSNP-810°ª©ó¤¹³\¾¯¶q¨â¿(8§J)¤§Á{§É¸ÕÅçµ²ªG:¥Dn«ü¼Ð¡G¦U²ÕALT®pÈ»Pµ¹ÃÄ«e¤§°ò¦Ȭۤñ¤§¦Ê¤À¤ñµL²Îp¤WÅãµÛ®t²§......... ------------------------------------------------------------------------------
¤½¥q¶È¤å¦r±Ôz8§JÁ{§É¸ÕÅçµ²ªG¡A¥D¦¸µ¥«ü¼Ð¨Sµ¹¥X[¼ÆÈ]¡AÅ¢²Î¤£²M´·¡A¦nÃa´N¬O¤½¥q»¡¤Fºâ¡A§Æ±æ12g¤½§i®É¯à¤@¨Ö»¡©ú¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/20 ¤U¤È 02:33:45
²Ä 3706 ½g¦^À³
|
¾ú¥v¤Wªº¤µ¤Ñ¡A¦h¤Ö¨Æȱo§ÚÌ°O¦í¡H(³o¸J½Ñ¸¯Âû´ö¤@¼Ëªo¿°¤S¸{¡AG¸z¤£¦nªÌ¤£n³Ü¡A§Ú¤£¬OÃį«¤]·|¿ù¦a!)
1.2021/12/16 -3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»· 2.2022.1.5-°ê¹©COVID-19ÃĤG´Á¸Ñª¼¹F¼Ð 4¤ë¥Ó½Ð¬üEUA 3.2024.3.20 ¤hªL¦aÀ˸p«¤j¸gÀ٥Ǹo±M²ÕÀ˹î©x¡A´x´¤°ê¹©û¤u¯A¥ÇÃÒ¨é¥æ©öªk²Ä171±ø¡u«D±`³W¥æ©ö¡vµ¥¡A¯A¶û®¿¥Î¤½ ¥q¸êª÷¡A¤£ªkª÷ÃB¶W¹L¤d¸U¤¸...Á`µô§dÄR¥É¡B¸³¨Æªø¼B³Ó«i2¤H¡A¦U[¥æ«O3¦Ê¸U¤¸]
-------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/12 ¤W¤È 10:36:51²Ä 2443 ½g¦^À³ EUA¨Æ¥ó¬O«D±`ÄY«¸Û«H°ÝÃDªº¬µ¼u¤Þ«H¡A³o¤~¬O¯u¥¿¦M¾÷! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/31 ¤U¤È 07:48:31²Ä 2273 ½g¦^À³ 7/30«e³£¬O¥ÎÃIJÕ(97.9%©Î100%)·L¦n©ó¹ï·Ó²Õ¡A½Ö®Æ¨ì³Ì²×¼Æ¾Ú¬O¹ï·Ó²Õ100%[°fÂà]Àu©ó¥ÎÃIJÕ97.9%¡Aªí©ú¤½¥q¤§«e©ÜÅS¤£¹ê¼Æ¾Ú¡A³o¬O[«D±`] [«D±`] [«D±`] ÄY«ªº¸Û«H°ÝÃD! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³ 3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! -------------------------------------------------------------------------------------------- ¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/25 µo¨¥®É¶¡¡G16:29:53 µo¨¥¤H¡G´¿¤ì¼W 1.¸³¨Æ·|³q¹L¤é´Á(¨Æ¹êµo¥Í¤é):110/11/25 ... 8.Åܧó·|p®v¤§ì¦]:¥»¤½¥qÀç¹B¤ÎºÞ²zµ¥¾ãÅé¦Ò¶q 11.³Ìªñ¤G¦~«×¤w¥Ó³ø©Î§Y±N½s»s¤§°]°È³ø§i¬O§_´¿¸g·|p®v½Õ¾ã©Î´£¥X¤º ³¡±±¨î«¤j§ï¶i¨Æ¶µ¤§«Øij:¬O¡C«e¥ô¸ê¸Û·|p®v©ó°õ¦æ109¦~¦~«×°]°È³øªí¬d®Ö¥~¶Ô´Á¶¡..
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/20 ¤U¤È 02:20:01
²Ä 3705 ½g¦^À³
|
¾ú¥v¤Wªº¤µ¤Ñ¡A³ÌÁV¿|ªºÃĪ«¡¨¤þ®ñªâ¦b2009¤U¬[ ¡A¨º³Ì¦MÀIªºAPAP¤îµhÃĦó®É¤U¬[?
----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤W¤È 10:30:50²Ä 1514 ½g¦^À³ ¡§¥v¤W³ÌÁV¿|ªºÃĪ«¡¨¤þ®ñªâ¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡A¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«Acetaminophen¡¨ ¤]¬OÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡CFDA¦b2009¤U¬[¤þ®ñªâ!!! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤U¤È 12:39:13²Ä 1516 ½g¦^À³ 1¤ä³ÌÁV¿|ªº¤îµhÃÄ»P1¤ä³Ì¦MÀIªº¤îµhÃĪº¹L¶q¤¤¬r¦º¤`»P´N¶E¦¸¼Æ: ³ÌÁV¿|ªº¤þ®ñªâ¤îµhÃÄ: ¦Û 1972 ¦~ 9 ¤ë¥H¨Ó¡A³oºØÃĪ«»P¦Ü¤Ö 7109 ¤H³ø§iªº¦º¤`¦³Ãö¡A¨ä¤¤ 2110 ¤H¬O·N¥~¦º¤`¡A«æ¶E«Ç´N¶E¦¸¼Æ¼W¥[¤F³\¦h¿¡A³o¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD ³Ì¦MÀIªºAPAP¤îµhÃÄ: ...Á`Åé¦Ó¨¥¡A¥H©¹ªº¬ã¨s... [¨C¦~] 56 000 ¡V 78 000´N¶E¦¸¼Æ¡A 26 000 ¡V 34 000»Ýn¦í°|»P¦ôp¦³ 500 ¤H¦º¤`¡C ¤j¬ù¦³¦h¤Ö¦º¤`¤H¼Æ¦Û1972 ¦~ 9 ¤ë¥H¨Ó? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/20 ¤W¤È 11:48:05
²Ä 3704 ½g¦^À³
|
·s¼W(10g)¥H¤W12¤H¡A¤jÃļtn¬Ý?(Ó¤H¤£t³d¥ôºÝ¥X³o¸JÂû´öªo¿°¤S¸{¡AG¸z¤£¦nªÌ¤£n³Ü) «æ©Ê¹L¶q»P«½Æ¶WªvÀø¶qÄá¨ú¡]RSTI)»ÖÈ>10g
¹ï¤AñQ®ò°ò×ô¹L¶qºÞ²z«ü«n (With support from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc) www.tylenolprofessional.com/sites/tylenol_hcp_us/files/acetaminphen_overdose_treatment_info.pdf ¹ï¤AñQ®ò°ò×ô¹L¶q¥i¯àµo¥Í¦b«æ©Ê¹L¶q©Î¤ÏÂйL¶q®É¡C «æ©Ê¹ï¤AñQ®ò°ò×ô¹L¶q¬O«ü¦b 8 ¤p®É©Î§óµu®É¶¡¤ºÄá¤J¤¤¬r¶qªº¹ï¤AñQ®ò°ò×ô¡C ¦¨¤H©M«C¤Ö¦~¦b 8 ¤p®É©Î§óµu®É¶¡¤ºÄá¨ú¶W¹L 7.5 ¦Ü[10§J]....ºC©Ê¹L¶qÄá¨ú³QºÙ¬°«½Æ¶WªvÀø¶qÄá¨ú¡]RSTI¡^¡A¥H°Ï§O©óºC©ÊªvÀø¥ÎÃÄ¡C Äá¨ú¤¤¬r¶q¶W¹L 8 ¤p®É§Y³Qµø¬°«½Æ¶WªvÀø¶qÄá¤J
...¹ï©ó 6 ·³©Î¥H¤Wªº±wªÌ¡ARSTI ©w¸q¬°Äá¨ú 1) ¦Ü¤Ö(10g)©Î200 mg/kg¡]¥H¸û¤pªÌ¬°·Ç¡^¦b³æ¤@ 24 ¤p®É¤º.... ---------------------------------------------------------------------------------------------- 112¦~7¤ë31¤é¨ú±oTFDA®Öã¦P·N§ë»P¾¯¶q©ñ¤j¬°12§J(·s¼W12¤H¡A¦Xp48¤H)-10g*6¤H /12g*6¤H |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/20 ¤W¤È 08:52:56
²Ä 3703 ½g¦^À³
|
³o¶gÄw½X200~400±i(+21±i) / 600~800±i(+8±i) / 1,000±i¥H¤W(+11±i)¡A§C±µ400~600±i½æ¥X(-60±i¤j·§¬OÂ÷¾¥ÛªF¤¸½æ¥X?) |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/19 ¤U¤È 04:02:50
²Ä 3702 ½g¦^À³
|
1.Q&Aªº®É¶¡¦b¤½§i°ê»ÚÃļtñq¦X§@¨óij¤é«e¡A ¤£¬O¤j¼t½T»{¸ÕÅçµ²ªG¤£¦p¹w´Á«á¼¶¼g! 2.«ö·ÓQ&Aªº[¼Ï¯Ã¸ÕÅç]¦¬®×48¤H 2024¦~01¤ë29¤é:¾¯¶q4-8§J(¦Xp36¤H)¡A112¦~7¤ë31¤é¨ú±oTFDA®Öã¦P·N§ë»P¾¯¶q©ñ¤j¬°12§J(·s¼W12¤H¡A¦Xp48¤H) -------------------------------------------------------------------------------------------- 2020.12.21¤½§i»P°ê»ÚÃļtñqSNP-810¬ãµo¦X§@¨óij ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/14 ¤W¤È 10:10:39²Ä 394 ½g¦^À³ ½Ð°ÝSNP-810ªº¼Ï¯Ã¸ÕÅç¹wp¦¬®×´XÓ¤H¡H¦¬®×¦aÂI¡H SNP-810¬O·sÀø®Ä·sÃÄ¡A¬O¥H¥hÄY«¨x¬r©Ê¬°¥Øªºªº·sÃÄ¡ASNP-810ªº¼Ï¯Ã¸ÕÅçµø±ÂÅv±¡§Î¡A¹wp¦b¥xÆW(©Î°ê»Ú¦P®É)¦¬®×60¦ì°·±d¨ü¸ÕªÌ¡A§¹¦¨48¤H¡C(¥H¥¿±`¤H¶i¦æµL¨x¬r©Ê¸ÕÅç§Y¥i)¡A³o¬O¥»ÃĶ}µo¦¨¥\ªº·¥¤jÀuÂI¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/19 ¤U¤È 12:31:21
²Ä 3701 ½g¦^À³
|
FDA«e¥N²z§½ªøJanet Woodcock:¡K§Ṳ́£§Æ±æFDA±Ä¨ú°®¹w±¹¬I¨Ó¸Ñ¨M¹ï¤A酰®ò°ò×ôªº¨x¬r©Ê·ÀI¡A³Q»~»{¬°¬ONSAIDSÃÄ(ªü´µ¤ÇÆF)¤ñ(APAP)§ó¦w¥þ--->ÆZ¦³·N¨ýªº¤@¬q¸Ü! ------------------------------------------------------------------------------------------------
·í¥«³õ¥X²{[µL¨x¬r]APAP¥i¨ú¥N¸Ñ¨M[¦³¨x¬r]APAPªº¨x¬r©Ê¡AFDA¤£À³¸Ó±Ä¨ú¤z¹w±¹¬I? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/19 ¤W¤È 11:51:54
²Ä 3700 ½g¦^À³
|
2023.10.20-¦¨¤À³Q§P©wµL®Ä CVS¤U¬[³¡¤À«y¹Â·P«_ÃÄnews.cnyes.com/news/id/5352668 CVS Health (CVS-US) ¥¿±q³f¬[¤W¤U¬[¤@¨Ç«y¹Â©M·P«_ªvÀøÃĪ«¡A³o¨ÇÃĪ«§t¦³¤@ºØ³QÂå¥Í©M¬ã¨s¤Hû»{¬°µL®Äªº¦¨¤À¡C
³o®a³sÂêÃħ½ªí¥Ü¡A±N¤U¬[¤Ö¶q§t¦³¥h®ñµÇ¤W¸¢¯À§@¬°°ß¤@¬¡©Ê¦¨¤Àªº²£«~¡CCVS ¤]ªí¥Ü¤´±N¤pÄò¾P°â¡u³\¦h¨ä¥L¤fµÄ«y¹Â©M·P«_²£«~¡A¥Hº¡¨¬®ø¶OªÌªº»Ý¨D¡v¡C ------------------------------------------------------------------------------------------
¥Î¤F´X¤Q¦~¤£¨ã[¦³®Ä©Ê]ªº¡u¥h®ñµÇ¤W¸¢¯À¡v(¦~¾P18»õ¬ü¤¸)¯à¤U¬[¡A¥Î¤F´X¤Q¦~¦³¨x¬r[¤£¦w¥þ]ªºAPAP¡A«ç»ò´N¤£¯à¤U¬[? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/19 ¤W¤È 11:33:08
²Ä 3699 ½g¦^À³
|
¥Î¤F´X¤Q¦~ªºOTCÃĪ«¡A¦]¬°¨S¦³[¦³®Ä©Ê]¡AFDA¨M©w§¹¥þ¸T¤î¸Ó¦¨¤À!
2023.9.14-½w¸Ñ»ó¶ë¦¨¤À¡u¥h®ñµÇ¤W¸¢¯À¡v ¬üFDAÅU°Ý»{µL®Ä¡I250´Ú·P«_ÃÄ®£¤U¬[ ...ÅU°Ý¤p²Õ§ë²¼µ²ªG¥i¯à«P¨ÏFDA¨M©w§¹¥þ¸T¤î¸Ó¦¨¤À¡A±N¾ÉP¼Æ¦ÊºØ¦¨ÃĤU¬[¡C¦]¦¹¦³¶T©ö²Õ´´£¥Xĵ§i¡AYFDAn¨D¤U¬[ÃÄ«~¨Ã«·s°t¤è¡A·|³y¦¨¦¨ÃÄ¿ï¾Ü¤Î¨ÑÀ³´î¤Ö¡A¨Ã¹ï®ø¶OªÌ»PÂåÀøÅé¨t³y¦¨¤£¤pªº¼vÅT¡C ------------------------------------------------------------------------------------------------ ¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n½á¤© FDA µo¥¬¦æ¬F©R¥OªºÅv¤O¡A¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]»P[¦³®Ä©Ê].. |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/19 ¤W¤È 08:18:34
²Ä 3698 ½g¦^À³
|
2017.9.14-¬ü°ê°ê·|¼f¬d«D³B¤èÃÄ ¨âÄҥߪk¯ó®×±N¹ý©³§ï² FDA ¹ï«D³B¤è²£«~ªººÊºÞ¤è¦¡(¦]¬°¤¾ªøªk³Wµ{§Ç¡AFDA ªá¤F¤C¦~®É¶¡¤~n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i)
2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n½á¤© FDA µo¥¬¦æ¬F©R¥OªºÅv¤O¡A¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]»P[¦³®Ä©Ê]¡AFDAª½µo¤@¯È¦æ¬F©R¥O¡A¤£¥Î¦A¨«¦Ñ®Mªº¤¾ªøªk³Wµ{§Ç¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 06:41:22²Ä 694 ½g¦^À³ ¥H²{¦bÃĪ«¤W¥«¼f¬dì«h¡AAPAP¬O¤£¥i¯à¦b¬ü°ê»P^°ê¤W¥«¡C ... 2020¦~3¤ë27¤é¤t´¶Ã±¸pªº¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n´N¬On¸Ñ¨M³oÃþÃĪ«ªº°ÝÃD¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/4 ¤U¤È 05:35:26²Ä 461 ½g¦^À³ 1972¦~FDA¥l¶°¤F¤@²ÕÂå¥Í©M¬ì¾Ç®a¨Óµû¦ô¤îµhÃÄ(¥]¬A¹ï¤A酰®ò°ò×ô)..µ²ªGªá¤F48¦~©|¥¼¸Ñ¨M¨x¬r©Ê¡C Orz. ¨S·Q¨ì¨g¤HÁ`²Î¤t´¶¤jµ§¤@´§µ¹³o³õÀ¸²K¦â¤£¤Ö! 1. 2012¦~1¤ë24¤é ---®Ú¾Ú±`ÃÑ¡AFDA¤µ¤Ñ¤£·|§åãªü¥q¤ÇªL¡A§ó¤£¥Î»¡¤¹³\¨ä¦¨¬°«D³B¤èÃÄ(OTCÃĪ«)¡C ¹ï¤A酰®ò°ò×ô(APAP)¤]¬O¤@¼Ë¤£·|§åã¡]¦b¬ü°ê¡A¹L¶q¨Ï¥Î¬O¾ÉP¨x°IºÜªº¥Dnì¦]¡^ www.reutersevents.com/pharma/commercial/pharma-marketing-and-sales-when-make-rx-otc-switch
2. 1975¦~12¤ë13¤é(¨S¼g¿ù¦~¥÷1975) ^°êÂå¥ZLancet¦b1975¦~ªºªÀ½×:¦pªG¸ÓÃĪ«(APAP)¡§¤µ¤Ñ³Qµo²{¡A¥¦±N¤£·|³Q^°êºÊºÞ¾÷ºc§å㡨¡C ¸ÓÂø»xªº½s¿è©eû·|ºÙ¸ÓÃĪ«ªºªí±¦w¥þ©Ê¡§¨ã¦³´ÛÄF©Ê¡¨¡C¥LÌ«ü¥X¡A¡§¤£¶W¹L«Øijªº³Ì¤j¨C¤é¾¯¶q¡¨¥i¯à·|¤Þ°_¨x·l®`¡A¦Ó¹ï¤A酰®ò°ò×ô¤¤¬r¤w¸g¬O^°ê¨x°IºÜªº¡§³Ì±`¨£ì¦]¤§¤@¡¨¡C www.documentcloud.org/documents/760638-lancet-para-hepa.html#document/p3/a121151 (¶À¦â®Ø¤ºªº¤å¦r) PS:1956¦~¡A¸¯Äõ¯À¥v§J¡]GSK¡^ 500mg¤@¤ùªº¤AñQÓi×ôÃĤù¦b^°ê¹Ò¤º¤W¥«¾P°â¡A°Ó«~¦WPanadol¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/18 ¤U¤È 07:43:41
²Ä 3697 ½g¦^À³
|
FDA«e¥N²z§½ªøJanet Woodcock:¡K§Ṳ́£§Æ±æFDA±Ä¨ú°®¹w±¹¬I¨Ó¸Ñ¨M¹ï¤A酰®ò°ò×ôªº¨x¬r©Ê·ÀI¡A³Q»~»{¬°¬ONSAIDSÃÄ(ªü´µ¤ÇÆF)¤ñ(APAP)§ó¦w¥þ--->ÆZ¦³·N¨ýªº¤@¬q¸Ü!
------------------------------------------------------------------------------------------------ ©³¤UFDA¸ê®Æ¤@¼Ë¼Ö¼Öªø... 1.·í¦³µLªk½T©wªº¤@¸s¤H·|µo¥ÍÄY«°Æ§@¥Î®É¡A«ö©¹¨ÒFDA·|«Øij±q¥«³õ¤WºM®ø¸ÓÃĪ«¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/18 ¤U¤È 07:38:27
²Ä 3696 ½g¦^À³
|
·í12g[¥xÆW¤HÅéÁ{§É¹êÃÒ]SNP-810¹L¶qµL¨x¬r©Ê¡A¤jÃļt¨Ì¶̩I©I¦b·N¤§«eªº½T»{¸ÕÅç(°Êª«¼Ò«¬)µ²ªG¤£¦p¹w´Á? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/18 ¤U¤È 07:23:46
²Ä 3695 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/3 ¤W¤È 08:40:44²Ä 890 ½g¦^À³ Á}Ãøªº¥¿Å-¯kµhºÞ²z¡AÃĪ«¦w¥þ©Ê©MFDA(Janet Woodcock, M.D.) www.nejm.org/doi/full/10.1056/NEJMp0908913 -------------------------------------------------------------------------------------------
(FDA)«e[¥N²z§½ªø] Janet Woodcock¦b2009¦~¼gªº1½g¤å³¹! ÁöµM¹ï¤AñQ®ò°ò×ô¦b«ö¼ÐÅҨϥήɳq±`¬O¦w¥þªº¡A¦ý¸ÓÃĪ«ªº´¶¹M¦s¦b¤Î¨ä¬Û¹ï[¯U¯¶ªºªvÀø«ü¼Æ]¥i¯à·|¦]µL·N©M¬G·N¹L¶qªA¥Î¦Ó³y¦¨ÄY«¶Ë®`....
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/18 ¤U¤È 07:17:32
²Ä 3694 ½g¦^À³
|
·í¥«³õ¥X²{µL¨x¬rSNP-810¥i¥H¨ú¥N¨x¬r©ÊAPAP«á¡A(±ÂÅv)¤jÃļt»PFDA¤£¥i¯à¦³À³Åܦæ°Ê?
---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/26 ¤U¤È 04:06:47²Ä 1247 ½g¦^À³ ¶D³^«ß®v¹ï±j¥Íªº¯Á½ß¥D±i: Tylenol ªº³]p©M¾P°â¦³¯Ê³´¡A¨Ã¥B³B©ó¡§¦³¯Ê³´¥B¤£¦X²zªº¦MÀIª¬ºA¡¨ [¥i¨Ñ®ø¶OªÌ¨Ï¥Îªº²£«~À³¸Ó¨ã¦³¦X²zªº¦w¥þÃä»Ú]=½¦¨¥Õ¸Ü´N¬O:APAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶qªº¾¯¶q½d³ò¤Ó¯¶¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤U¤È 08:09:40²Ä 649 ½g¦^À³ ·í¥«³õ[µL]¨x¬rSNP-810¥i¥H¨ú¥N[¦³]¨x¬rAPAP«á¡A ¾Ö¦³SNP-810ªºÃļt¡A¤£·Qn¯Þ»K¦V¥~Ås¤ä«ùFDA¤U¬[APAP¦nºÙÅQ¤îµhÃÄ¥«³õ???
©³¤UFDA¸ê®Æ¤@¼Ë¼Ö¼Öªø...
1.·í¦³µLªk½T©wªº¤@¸s¤H·|µo¥ÍÄY«°Æ§@¥Î®É¡A«ö©¹¨ÒFDA·|«Øij±q¥«³õ¤WºM®ø¸ÓÃĪ«¡C
(¤]´N¬O»¡¦pªGNSAIDSÃĪ«¯àªø´Á¥N´ÀAPAP¡A¨º»òAPAP¤]¦³QFDA¤U¥«)
a.¿}§¿¯fÃÄRezulin¦]¶Ë¨x³QFDA¤U¥«(¥X²{´À¥NÃĪ«»P¨S¦³¬Û¦P°Æ§@¥Îªº·ÀI)
b.Phenylpropanolamine¥X¦å©Ê¤¤··ÀI³QFDA¤U¥«(¥X²{´À¥NÃĪ«¥B¨S¦³¬Û¦P°Æ§@¥Îªº·ÀI)
2.12¦ìCDER´î¤ÖAPAP¨x¬r¤u§@¤p²Õ¡A¥u¦³1¦ì¤u§@²Õû¤Ï¹ï®ø°£OTC¤¤ªº¹ï¤A酰®ò°ò×ô²Õ¦X²£«~¡C
-----------------------------------------------------------------------------------------------
2008.02.26
FDAªº«Øij¤z¹w±¹¬I¥H´î¤Ö¹ï¤A酰®ò°ò×ô¨x¬r©Êªºµo¥Í
Janet Woodcock
www.litigationandtrial.com/files/2011/12/2009-4429b1-02-FDA.pdf
¡K»P¨ä¥L¤îµhÃÄ¡]¥Dn¬O³Â¾KÃÄ©MNSAIDS¡^¬Û¤ñ¡A¥¦¥¿½T¨Ï¥Î¬O¬Û¹ï¦w¥þªº¡K§Ṳ́£§Æ±æFDA±Ä¨ú°®¹w±¹¬I¨Ó¸Ñ¨M¹ï¤A酰®ò°ò×ôªº¨x¬r©Ê·ÀI¡A[³Q»~»{¬°]¬ONSAIDSÃÄ(ªü´µ¤ÇÆF) ¤ñ (APAP)§ó¦w¥þ¡C
NSAIDS¡]¤×¨ä¬Oªø´ÁªA¥Î¡^·|¾ÉP«nªºG¸z¹D¯e¯f©MµÇŦ¯e¯f¡C¤z¹w±¹¬Iªº¥Øªº¬O´î¤Ö¹ï¤A酰®ò°ò×ô¬ÛÃöªº¨x¬r©Ê¡A¦Ó¤£¬O [´î¤Ö ] ¹ï¤A酰®ò°ò×ôªº¨Ï¥Î©Î ÅX¨Ï ¤H̨ϥÎNSAID¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/18 ¤U¤È 06:48:45
²Ä 3693 ½g¦^À³
|
¦¶³Í¥Áªí¥Ü¡AµL¨x¬r©Ê¤îµhÃÄSNP-810¡]¦w®õ®³¯k¡^©ó2020¦~¡B2021¦~¤À§O»P2®a°ê»Ú¯ÅÃļtñq¦X§@¨óij¡AµL©`´Á¶¡¨ä¤¤¤@®a¦X§@¼t°Ó½T»{¸ÕÅçµ²ªG¤£¦p¹w´Á¡A¥HP¦X§@¤¤¤î¡C ------------------------------------------------------------------------------------
½T»{¸ÕÅç(°Êª«¼Ò«¬)µ²ªG¤£¦p¹w´Á-->¦X§@¤¤¤î¡C 4~12gÁ{§É¸ÕÅç(¤HÅé¸ÕÅç)-->Á{§É¹êÃÒµL¨x¬r¡A¤£¥i¯à«±Ò¦X§@? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/4/18 ¤U¤È 02:43:00
²Ä 3692 ½g¦^À³
|
³oºØ¤u¥qªºÃħAÁÙ´±¶R¶Ü?¥u¦³Jp¼L¤W´±¦Y¡A¤U¦¸ªíºt¤@¤U¦Y¾ã²~¨Ó¥[±j«H¤ß¡C·dªº¹³¤ßµ|¤@¤U¤U¥«¡A¦Yºë¯«¯fªºÃÄ¡C°£«D¦³¤j¶Ìb¦¬ÁÊ¡A¤£µM«~«O¤£´±¬Û«H¡C¦ý¥xÆWªº°ªºÝÁÙ¬O¤ñ¹ï©¤ªº¬ì¿³¦n¡A¬ì¿³³£¦¬°_¨Ó¤F¡C426ªº¾Þ§@²r¡Aª½±µË³¬§A¥h¨ºú¡C¬Û¤ñ¤U¨Ó·sÃÄÁÙ¦³60 «¢ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/4/18 ¤W¤È 11:39:14
²Ä 3691 ½g¦^À³
|
¨º¨Ç¤@ª½¤ßÆFÂû´öªºn¤£n¥X¨Óºë¯«³Û¸Ü¤@¤U?
ÁÙ¬O»¡¥ý¶^¨ì5¤¸¡AµM«áº¦1000%¨ì50¤¸!! ¤j®a»¡¦n¤£?
¨º¨Ç¤ßÆFÂû´ö¤j®vÁÙ¥i¥H¦³¥x¶¥¤U¡A¥L̨ì®ÉÔ·|»¡: ½T¹ê¬Oº¦1000%ªü¡A¦ý¬O¥LÌ·íªì¨S»¡¬O±q´X¤¸°_º¦!! |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G¤p¨k¤H10151116 |
µoªí®É¶¡:2024/4/18 ¤W¤È 11:00:23
²Ä 3690 ½g¦^À³
|
¦Û±q¥X²M«á¡A«Ü¤[¨S¨Ó³oª©¡A¥u¯à»¡ÁÙ¦n¤§«eÂà¨ì¥xg§âÁ«·l³£¸É¦^¨Ó¤F ÁÙ¦n»{²M«Ü¦h¨Æ¹ê¡A¤]«ùÄò¯¬ºÖÁÙ¦bªYÄ£²î¤Wªº¤ä«ùªÌ¡A¦³§A̤~·|¦³µL¬rÃÄ¥X¨Óªº¨º¤Ñ §Ú¹ïªYÄ£ªºµL¬r810ÁÙ¬Oı±o¤£¿ù¡A²£«~¥X¨Ó§Ú¤]¤@©w¶R¡A¥u¬OªÑ»ù´N¤£´Á«Ý
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/4/18 ¤W¤È 10:59:50
²Ä 3689 ½g¦^À³
|
¦nºG ¯}60¤F~~¤F¸Ñ°ê¨¾Â媺¤ô·Ç ¤jªÑªFÁÙ¤£¶R¼É!!!!¥x¿n¼Q¨ì¥~¤ÓªÅ¡A·sÃÄÁÙ¯}©³¡A¤@¤Ñ50%¡AÁÙ¬O½ß¥»¡A©Ò²æ«D¤H |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/4/18 ¤W¤È 09:00:23
²Ä 3688 ½g¦^À³
|
¤£¦Ûı·Q¦R¼Ñ¤@¤U¡A 12g ¼Æ¾Ú¥X¨Ó¤S¦p¦ó? ¤j¼tÁÙ¬O¤£¶R³æªü¡A§A¼Æ¾Ú¦Aº}«G¡A¤j¼t´N¬O¦³Àq«´¤@°_¤£¶R³æ´N¦n ¥«³õÁÙ¬O¥LÌÃbÂ_¡A©Ò¥HªYÄ£¤S¯à®³¥L̦p¦ó? Á¿¥Õ¤F´N¬OªÅÀY¥q¥O¡A©³¤U¨S§L¡A ¯à°÷¦R¼ÑªºÂI¹ê¦b¤Ó¦h¤F¡A¤£ª¾¹D±q¦ó¦R¼Ñ°_¤F~ ªÑ»ù³Ì¯à¤ÏÀ³¯u¹êª¬ªp¡A¯u¨º»òÎx¡A¤jªÑªFÁÙ¤£¥[½X¶RÃz? ¨S¤Hn¶R¥Nªí¤°»ò?¤jªÑªF¤@©w³£¬O³Ìª¾¹D¯u¹ê±¡ªpªº....
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/17 ¤U¤È 04:30:55
²Ä 3687 ½g¦^À³
|
µ¥12gªº¼Æ¾Ú¤½§i! 4~8gªºÁ{§É¹êÃÒ¹ï¤ñ¦p¤U: --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/2/10 ¤U¤È 03:51:12²Ä 3648 ½g¦^À³ 4-8g SNP-810 VS. 4g APAP ªYÄ£µL¨x¬r¤îµh·sÃÄSNP-810(8§J)¤§Á{§É¸ÕÅçµ²ªG
¥Dn«ü¼Ð¡G¦U²ÕALT®pÈ»Pµ¹ÃÄ«e¤§°ò¦Ȭۤñ¤§¦Ê¤À¤ñµL²Îp¤WÅãµÛ®t²§¡Aªí¥Ü¨Ï¥ÎSNP-810¨ä¤AñQÓi×ô¾¯¶q¨C¤Ñ4-8§J(¬°¹L¥h®Öã¤W¨C¤Ñ4§Jªº2¿)§¡¥¼²£¥Í¨x¬r©Ê¡C¦¸n«ü¼Ð¡G¦U²Õ¦bALT®pȧ¡¥¼¶W¹L2¿¥¿±`È¡A§YALT¤É°ª¤j©ó2~8¿¥¿±`ȤW¤§¤ñ¨Ò¬°0%¡C
VS. 2006.7.5--°·±d¦¨¤H¨C¤Ñ±µ¨ü(4§J)¹ï¤AñQ®ò°ò×ôªºÂà®ò酶¤É°ªÀH¾÷¹ï·Ó¸ÕÅç µ²ªG:....±µ¨ü¹ï¤AñQ®ò°ò×ôªvÀøªº 4 ÓªvÀø²Õ¤¤...³Ì¤j ALT ¶W¹L¥¿±`¤W3¿ªºµo¥Í²v¬° 31% ¦Ü 44%¡C»P¦w¼¢¾¯¬Û¤ñ¡A¹ï¤AñQ®ò°ò×ôªvÀø»PÅãµÛ¸û°ªªº¤¤¦ì¼Æ³Ì¤j ALT ¬ÛÃö¡]¤¤¦ì¼Æ¤ñ¡A2.78¡F95% ¸m«H°Ï¶¡¡A1.47-4.09¡FP <.001¡^¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gªiªi10151449 |
µoªí®É¶¡:2024/4/17 ¤W¤È 10:16:27
²Ä 3686 ½g¦^À³
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/15 ¤U¤È 07:44:38
²Ä 3685 ½g¦^À³
|
¤@¥¹10-12g¼Æ¾Ú(¼Ï¯ÃÁ{§É¸ÕÅ礧¤@)ÃÒ¹êSNP-810¹L¶qµL¨x¬r©Ê¡A«ö112¦~³ø¤º®e´N¬O¶i¦æµL¨x¬r·sÃÄ[¬dÅçµn°O¼f®Ö]!
¥xÆW½ÃºÖ³¡®Öã¶i¦æ°ª¾¯¶q¤fªAÁ{§É¦w¥þÅçÃÒ¸ÕÅç:¥»®×«Y¥H¶W¹L¥Ø«e°ê¤º¥~¥é³æ¤W±ÀÂˤ§¾¯¶q¦V¥xÆW½ÃºÖ³¡¥Ó½Ð¤HÅé¸Õ Åç¡A¨ÃÀò®Öã°õ¦æ¡Aªí¥Ü½ÃºÖ³¡¤w±µ¨ü SNP-810 ¦b°Êª«¤Î¤HÅé(¥¿±`¾¯¶q¤U¬r©Ê¥NÁª«´î¤Ö)¸û°ª¾¯¶q¤§¦w¥þ©Ê¡C¦¹¤HÅéÁ{§É¸ÕÅç³]p¬°³æ¤¤¤ß¡B³æª¼¤Î¦h¾¯¶q¤fªAÃĪ«¨î©Ê¨x¬r©ÊÃĪ«°Ê¤O¾Ç¸ÕÅç¡A§ë»P¤AñQÓi×ô¾¯¶q 4 ¦Ü 8 §J¡A ¹wp¦¬®× 36 ¦ì°·±d¨ü¸ÕªÌ¡C¦]¸Ó¸ÕÅ羯¶q¤w¶W¹L²{¦æ¤AñQÓi×ôÃÄ«~»¡©ú®Ñ®Öã¨Ï¥Î¨C¤é³Ì¤j¾¯¶q 4 §J¡A«S¨ú±oÁ{§É¦w¥þµ²ªG«á¡A¥iª½±µÃÒ¹ê SNP-810¹L¶q¤]µL¨x¬r©Ê¡A [¥i¦V½ÃºÖ³¡¹Ãĸp¿Ô¸ß·sÃÄ®Öã¤W¥«¡A¨Ã½Õ¾ãÃĪ«¥é³æ¦p§R°£¨x¬r©Ê¡B¼W¥[¨C¤é¥i¤¹³\¾¯¶qµ¥]... [¥i¦V½ÃºÖ³¡¹Ãĸp¿Ô¸ß·sÃÄ®Öã¤W¥«¡A¨Ã½Õ¾ãÃĪ«¥é³æ¦p§R°£¨x¬r©Ê¡B¼W¥[¨C¤é¥i¤¹³\¾¯¶qµ¥]... [¥i¦V½ÃºÖ³¡¹Ãĸp¿Ô¸ß·sÃÄ®Öã¤W¥«¡A¨Ã½Õ¾ãÃĪ«¥é³æ¦p§R°£¨x¬r©Ê¡B¼W¥[¨C¤é¥i¤¹³\¾¯¶qµ¥]... ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/30 ¤U¤È 11:44:13²Ä 3638 ½g¦^À³ 10-12g³¡¤À¸ê®Æ¥¿¦b¤ÀªR¾ã²z¤¤¡A«Ý§¹¦¨«á¡A±N¦Aµo«°T¤½§i¤Î¶i¦æ[¬dÅçµn°O¼f®Ö]¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/11 ¤U¤È 10:05:04
²Ä 3684 ½g¦^À³
|
¤H¤u²¢¨ý¾¯¥i¯à¦¨¬°ªvÀø²´¯eªºÃĪ«?
2024.4¤ë¼w°êµoªíªº¬ã¨s: ±´°Q[¿}ºë]¹ï·s¥Í¦åºÞ©Ê¦Ñ¦~¶À´³³¡¯fÅܪº¼vÅT¡G¹ï±wªÌ©M¤p¹«ªººî¦X¬ã¨swww.ncbi.nlm.nih.gov/pmc/articles/PMC10996979/
µ²ªG CNV ¬¡°Ê±±¨î¨}¦nªº±wªÌ ( P = 0.004) ©M¨S¦³µøºô½¤¤U°ª¤Ï®g§÷®Æªº±wªÌ ( P = 0.015)ªº¦å²G¤¤¿}ºë¤ô¥ÅãµÛ¸û°ª¡C¦b¤p¹«¼Ò«¬¤¤¡A¿}ºë³B²zªº¤p¹«ªí²{¥X¸û¤Öªºº¯º|¹p®g¬Í²ª¡B¸û¤Öªº¥X¦åµo¥Í¡B¸û¤pªºÅÖºû¤Æ°Ï°ì¡]P<0.05¡^¥H¤Î³æ®Ö§]¾½²ÓM²Ö¿n´î¤Ö40%¡]P = 0.06¡^¡C°ò¦]¤ÀªRÅã¥Ü±µ¨üªvÀøªº°Êª«¤¤µoª¢©M VEGFR-1 ¤ÏÀ³°ò¦]¤U½Õ¡C ... Á`¤§¡A§ÚÌ»{¬°§Ú̪º¬ã¨sµ²ªG¬°¿}ºë¡]¥H¤Î¨ä¥L¥i¯àªº¤H¤u²¢¨ý¾¯¡^§@¬°²´·ú·s¥Í¦åºÞ¯e¯fªº¼ç¦b½w¸Ñ¾¯´£¨Ñ¤F¥t¤@ӰѦҡA¨Ã¥B¬O·s¥Í¦åºÞ©Ê¦Ñ¦~¶À´³³¡¯fÅܤ¤ªº²Ä¤@ÓÁ{§ÉÃÒ¾Ú.... ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/8 ¤W¤È 07:29:11²Ä 3612 ½g¦^À³ 2018.10.23- ¤H¤u²¢¨ý¾¯¦p¦ó´î¤Ö¿}§¿¯f¬ÛÃöªº²´³¡¦åºÞ·l¶Ë link.springer.com/article/10.1007/s00417-018-4157-8 ¿}§¿¯f±wªÌ³Ì±`¨£ªº·L¦åºÞ¨Öµo¯g¤§¤@¬O»Pµøºô½¤¤º¥Ö¦åºÞ§Î¦¨¼W¥[¬ÛÃöªº¿}§¿¯fµøºô½¤¯fÅÜ¡]DR¡^ µ²ªG ...§Ú̶i¤@¨BÃÒ©ú¡A[¤T´â½©¿}]¥i´î®z VEGF »¤¾Éªº Akt ÁC»Ä¤Æ¡A¶i¦Ó«OÅ@µøºô½¤·L¦åºÞ¨t²Î¡C
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/4 ¤U¤È 04:16:05
²Ä 3683 ½g¦^À³
|
³o¬O«þ¨©ªºÃĪ«¾÷¨î¬ã¨s??? (SNP-6ÃĪ«¿ï¦Û:[¸t¯ó×ô]¡B[¥ÌÅS¾J]¡BÁ¡²ü¾J¡B[¤T´â½©¿}]¡B¡B¡B) (SNP-810:[¥ÌÅS¾J]+[¤T´â½©¿}])
2024.1.17-¬ü°ê¦è©`¤s¥ì§¢Âå¾Ç°|:¸É¥R[¥ÌÅS¿}]³z¹L§í¨îªG¿}¥NÁ¨ӧí¨î¤p¹« MASH ¨xŦ¯×ªÕÅÜ©Ê©MÅÖºû¤Æ www.biorxiv.org/content/10.1101/2024.01.17.576067v1 ¥NÁÂ¥\¯à»Ùê¬ÛÃöªº¯×ªÕ©Ê¨xª¢¡]MASH¡^¥i¶i®i¬°¨xµw¤Æ©M¨xÀù¡C¨S¦³§å㪺ÃĪ«Àøªk¥i¥H¹w¨¾©Î°fÂà¯e¯f¶i®i¡CªG¿}¤Î¨ä¦b¨xŦ¤¤ªº¥NÁ¦b MASH µo¯f¾÷¨î©M¶i®i¤¤µo´§µÛ¤£¥i©Î¯Êªº§@¥Î¡C¦b³o¸Ì¡A§ÚÌ«ÂIÃöª`¥ÌÅS¿}¡A¤@ºØ³æÁÞ¡A¥¦¥i¥H§í¨î¨x¬Pª¬²ÓMªº¬¡¤Æ¡A¨Ã¦bÅé¥~©MÅ餺´î»´°sºë©Ê¨x¯f¡C¦b¸g¹L¥R¤ÀÅçÃÒªºFAT-MASH ¤p¹«¼Ò«¬¤¤¡AµL½×¬O¦b¼Ò«¬¶}©l®É¡]¡u¹w¨¾¡v¡^©Î¦b12 ¶gMASH ªº²Ä6 ¶g¬I¥Î¡A¤fªA¥ÌÅS¿}¸É¥R¾¯¦b§C¾¯¶q©M°ª¾¯¶q¤U§¡¥i§ïµ½¨xŦ¯×ªÕÅÜ©Ê©MÅÖºû¤Æ¤è®×¡]¡§°fÂࡨ¡^¡C¸É¥R¥ÌÅS¿}ªºÅ餺§ÜÅÖºû¤Æ§@¥Î¦b²Ä¤GÓ¥|´â¤ÆºÒ»¤¾Éªº¨xÅÖºû¤Æ¼Ò«¬¤¤±o¨ì¤FÅçÃÒ¡C
----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 08:57:53²Ä 926 ½g¦^À³ «ç»ò¶}©l¬y¦æ¦Y¿}ªvÀø¨x¬r???(ÁÙ¯u¦³®Ä!) 2021.2.23 °ªªG¿}¶¼¹¥i¥H¹w¨¾ÃĪ«¤Þ°_ªº¨x·l¶Ë¶Ü¡H aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1683 ¤@Ó¬ã¨s¤p²Õ±´°Q¤F¦b¤p¹«¤¤¹ï¤A酰®ò°ò×ô¹L¶q®É¹¥Î´I§tªG¿}ªº¶¼¹ªº«OÅ@¯à¤O¡C ..±i¼w±j³Õ¤h»â¾Éªº¤@¶µ·s¬ã¨s¤¤¡C±K·²®Ú¤j¾ÇÂå¾Ç°|¤À¤l»P¾ã¦X¥Í²z¾Ç¨tªº¤@¦ì¬ã¨s¤Hû¡A®ï±Ð±Â©M¤@²Õ¬ã¨s¤Hû..¡§§Ú̵o²{¡A¦b¤p¹«¤¤¡A¦b¹ï¤A酰®ò°ò×ô¹L¶q¤§«eµu®É¶¡¹¥Î°ªªG¿}¶¼¹¹ê»Ú¤W¥i¥H´£¨Ñ§Ü¨x·l¶Ëªº«OÅ@¡A¡¨ Yin»¡¡C¡§³o¯u¥O¤HÃø¥H¸m«H¡C¡¨ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/4/3 ¤U¤È 09:00:02
²Ä 3682 ½g¦^À³
|
¡uªü§Lô¡A¦YÄCÀY¡A¬ÝµÛ¬d¬Y³n·d·d¡C ¡v ÄCÀY¦Y¤Ó¦h¡A°Æ§@¥Î¬OÀY©ü²´ªá@ -------------------------------------------------
mops.twse.com.tw/mops/web/query6_1 ¸ê®Æ¦~¤ë¡G11303 ¸³¨Æªø¥»¤H ¦¶³Í¥Á ¿ï¥ô·í®É«ù¦³ªÑ¼Æ 1,415,500 ¤W¤ë¹ê»Ú«ù¦³ªÑ¼Æ 1,667,500 ¥»¤ë¹ê»Ú¦Û¦³«ù¦³ªÑ¼Æ1,742,000 ¥»¤ë¼W¥[74,500 |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/3/22 ¤W¤È 10:28:17
²Ä 3681 ½g¦^À³
|
¥i¯à¬O¬Ý¨ìªÑªF¤ñ¤½¥qû¤uÁÙ»{¯u¡C Ãø±o¦³»¡ªk¡A·|¤£·|¥u¬O°Ê°Ê¼L¥Ö?? ¦nªº±¹³¨Ó»¡¡A¦Ü¤Ö¦³¤ÏõX¤F¡CªÑ»ù³£¬O¤@³õ¹Ú¡A¹ï¤£°_ªÑªF¡A¦ý¦Û¹¡¤F¤£¤Ö¡C¦Û¤w¦Y¦Û¤w¬ãµoªº°¤@¤U¯×ªÕ¨x¡CÁÙ¬O¦Û¤w¤]¤£´±¦Y??¥u¦³JP»¡¦³¦Y ========================================================================== ¤Þ¥Î¦P¾Ç·|ªº¤pµæ³¾¦^À³:¨S¦³°Õ¡AÁÙ¬O¦³°µ¨Æ¡A¾Ç¤½°Èû¤@¼Ë¥´²VºN³½»âÁ~¤ô´Â¤E±ß¤¡AµM«á¤u§@¤é»x¶ñ¦n¶ñ¦n¬Ý°_¨Ó«Üºë¬ü¡AÅý¤H¬Ý¤Fı±o¤u§@¶q«Ü¤j«Ü¥R¹ê¡Aµ¥þ¤Ñ³Q©ñ¤jÀ˵ø®É¡A¤~·|Ååı¨ä¹ê¤°»ò³£¨S°µ~ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/20 ¤U¤È 07:14:40
²Ä 3680 ½g¦^À³
|
MASHÃĪ«»Ý«O«ùªø´Á°ª¦w¥þ©Êªº°ª¼Ð·Ç Akeroªºefruxifermin ±`¨£¤£¨}¨Æ¥ó¬O1~2¯Å(»´«×¦Ü¤¤«×)G¸z¹D¸¡Âm(¬ù40%¥ÎÃĪÌ) 2022.9.13¤½¥¬24¶g¼Æ¾Ú®É¬O1¨ÒÄY«¤£¨}¨Æ¥óir.akerotx.com/news-releases/news-release-details/akero-therapeutics-phase-2b-harmony-study-both-50mg-and-28mg-efx/
96¶g®É¦³15¨ÒÄY«¤£¨}¨Æ¥ó(>3¯Å)¡A¤]¬O¼ìºÅ©Ê¹¹Dª¢???
----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/3/9 ¤W¤È 09:42:28²Ä 3664 ½g¦^À³ ©µªøF1~F3ªvÀø´Á¡AM(52¶g)»PA(96¶g)³£©úÅã±a¨Ó§ó¦nªºµ²ªG! ... (§Úµû:¦@³ø§i¤F15¨ÒÄY«¤£¨}¨Æ¥ó¡A¨S¬Ý¨ìAkero»¡©ú¡A¦³Áô¼~!) |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/20 ¤U¤È 06:51:44
²Ä 3679 ½g¦^À³
|
2024/03/20-ªYÄ£¥ÍÂå°w¹ï¬ü°êFDA®Ö㠲Ĥ@ÓªvÀø¥NÁÂ¥\¯à»Ùê¬ÛÃö¯×ªÕ©Ê¨xª¢ MASH ÃĪ«¤§³ø§i¤Î¦]À³±¹¬I ...°ê»Ú³»¯ÅÅv«ÂÂå¾Ç´Á¥Z¨ë¯Þ°w-G¸z»P¨xŦ (The Lancet Gastroenterology & Hepatology) µû½×:¾¨ºÞ³o¶µµ²ªG¥O¤H¹ª»R¡A¦ý¦Ò¼{¨ì¸ÓÁ{§É¸ÕÅç¶È¥HªvÀø52¶g¼Æ¾ÚÁö²Å¦XFDA»P¼Ú¬wÃÄ«~§½(EMA)¦´Á§å㪺n¨D¡A¦]¦¹¤´µMµLªk±oª¾¸ÓÃĹï MASH¶i®i¬°¨xµw¤Æ¥H¤ÎÀH¤§¦Ó¨Óªº¨x°IºÜ¡B²¾´Ó©M¦´Á¦º¤`²vªº¼vÅT¡A¦¹¥~¦Ò¼{¨ìªø´ÁªvÀøªº»Ý¨D¡A¹ï©óResmetirom¤´»Ý«O«ùªø´Á°ª¦w¥þ©Êªº°ª¼Ð·Ç(µù2)¡C
¥t¥~ȱoª`·Nªº¬O¡A¥Ñ©óMASHªºP¯f¾÷Âà¹L©ó½ÆÂø¡A¦]¦¹¤£½×¬OFDA©Ò§å㪺Resmetirom§í©Î¬O¨ä¥L°w¹ï¤£¦PP¯f¾÷Âà©Ò§¹¦¨ªºÃĪ«³æ¤@ÀøªkÁ{§É¸ÕÅç¡A»P¦w¼¢¾¯²Õ§O¬Û¤ñ¡AMASH±wªÌªº¨xŦ²Õ´¯f²z½w¸Ñ¤ñ¨Ò¤£¶W¹L32%¡A¸ÑÄÀ¤F¬°¦ó²{¤µ¶}µoªvÀøMASH³æ¤@ªvÀø¼Ð¹v¤£¤Ó¨¬°÷(µù3¡A4)¡C¦]¦¹¦h¹vÂIªºÀøªk¡A§í©Î¬O²Õ¦XÀøªk³£¬O«æ»Ý¥B¢¤Áªº¡C .... µ²ªGÅã¥Ü±wªÌªA¥Î°ª¾¯¶qSNP-610²Õ§O¡A¨ä¨xª¢«ü¼ÐALT¼ÆÈ¡A»PªvÀø«e¬Û¤ñ¤U°°ª¹F30U/L¡A¦Ó¦¹¼Æ¾ÚÀu©óResmetiromÁ{§É¤G´Á¼Æ¾Ú(µù5)¡C¥¼¨Ó°õ¦æSNP-630Á{§É¤G´Á«e¥²¶·°õ¦æ¤§¬r²z¸ÕÅç¥çÀò±oÂåÃÄ«~¬dÅ礤¤ßCDE¦P·N³¡¤À´î§K¡C²{¿n·¥·Ç³Æ±Ò°ÊSNP-610ÀH¾÷¡BÂùª¼¡B¦w¼¢¾¯¹ï·ÓÁ{§É¤G´Á¸ÕÅç¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/16 ¤U¤È 04:33:36
²Ä 3678 ½g¦^À³
|
2004¿Õ¨©º¸¤Æ¾Ç¼ú¡j³J¥Õ½èªº¤À¸Ñ¾÷¾¹ teaching.ch.ntu.edu.tw/nobel/2004 ĶªÌ¡þ½²Ä©ú¡U¥x¤j¤Æ¾Ç¨t¦WÅA±Ð±Â
¬ã¨s¦b²ÓM¤¤¦p¦ó¹ï¤@¨Ç¤£»Ýnªº³J¥Õ½è¥[¤W¤@ºØºÙ¬°ªx¯À(ubiquitin)ªº¦hÐ`肽¼ÐÅÒ¡AÂÇ¥H½Õ¸`¬Y¨Ç³J¥Õ½èªº¦s¦b¡A¥L̪º¬ã¨s¦b¤Æ¾Çª¾ÃѤW¦³«nªº¬ð¯}¡C³o¨Ç³Q¥[¤W¼ÐÅÒªº³J¥Õ½è¡A±µµÛ·|¦b¤@ÓºÙ¬°³J¥Õ¸ÑÅé(proteasome)ªº²ÓM¡§©U§£³B²z¾÷¡¨¤¤¨³³tªº°¸Ñ¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/16 ¤U¤È 04:23:27
²Ä 3677 ½g¦^À³
|
2023.8.26-USP14 ±±¨î CYP2E1¡A³z¹L HSP90AA1 ªº¥hªx¯À¤Æ©Méw¤Æ«P¶i«D°sºë©Ê¯×ªÕ¨x www.nature.com/articles/s41419-023-06091-6 ¬ã¨sµo²{¡AÀHµÛNAFLDªºµo®i¡A¨xŦUSP14ªºªí¹F¼W¥[¡A³oª½±µ¾ÉPCYP2E1ªº¼W¥[¡A»¤¾É§óÄY«ªºROS¡B²É½uÅé·l¶Ë©Mµoª¢¡C¬Û¤Ï¡A§í¨î CYP2E1 ¥i¥H°fÂà USP14 ¹L«×ªí²{¤p¹«ªº¨xŦªí«¬¡C³o¤]Åã¥Ü CYP2E1 ¬O USP14 ¥[¼@ NAFLD ¶i®iªº¼Ð¹v¡C --------------------------------------------------------------------------------------------------
§í¨î CYP2E1 ¥i¥H°fÂà USP14 ¹L«×ªí²{¤p¹«ªº¨xŦªí«¬ §í¨î CYP2E1 ¥i¥H°fÂà USP14 ¹L«×ªí²{¤p¹«ªº¨xŦªí«¬ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/16 ¤U¤È 04:18:18
²Ä 3676 ½g¦^À³
|
û¡GROGER588910148151 µoªí®É¶¡:2023/9/8 ¤U¤È 02:21:27²Ä 3442 ½g¦^À³ 2018¦~Nature¤l¥ZªºUSP14½×¤å¡AÂõۦnÅå¤Hªºª¯¦å¼@±¡! Orz. ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/26 ¤U¤È 07:31:12²Ä 3424 ½g¦^À³ ¼ö©I©IªºNature¤l¥Z½×¤å. USP14 ¦b LPO ©Mª¢¯g¤¤ªº¥\¯à¨ú¨M©ó CYP2E1 --------------------------------------------------------------------------------
1.2004¦~¿Õ¨©º¸¤Æ¾Ç¼ú(³J¥Õ½èªº¤À¸Ñ¾÷¾¹):¬ã¨s¦b²ÓM¤¤¦p¦ó¹ï¤@¨Ç¤£»Ýnªº³J¥Õ½è¥[¤W¤@ºØºÙ¬°[ªx¯À]ªº¦hÐ`肽¼ÐÅÒ¡A ½Õ¸`³J¥Õ½èªº¦s¦b¡F¥L̪º¬ã¨s¦b¤Æ¾Çª¾ÃѤW¦³«nªº¬ð¯}¡C
2.¦p¦ó¹B¥Î²ÓM¾÷¨î§ïµ½¯×ªÕ¨x¡H¥ý¨Ó»{ÃѤ°»ò¬O[ªx¯À]»P[²ÓM¦Û¾½] research.sinica.edu.tw/ubiquitination-autophagy-liver/ ¥¼¨Ó¦³±æÀ³¥Î¨ì¯×ªÕ¨xªvÀø ²ÓM¦Û¾½¬O¤j³¡¥÷²ÓM¦Û§Ú½Õ¾ã¡B«O«ù¥¿Åªº«n¤â¬q¡A¦b¬Y¨Ç¯S®í²Õ´§ó§êºt«n¨¤¦â¡A¨Ò¦p¨x²ÓMªº¥NÁ¡C¹L¥h¬ã¨s µo²{¡A¦pªG²ÓM¦Û¾½¥\¯à¯Ê¥¢¡A®e©ö¾ÉP¯×ªÕ¨x§Î¦¨¡C ³¯·çµØ¹Î¶¤¨Ï¥Î¤p¹«§@¹êÅç°Êª«¡A±´°Q²ÓM¦Û¾½¦b«D°sºë©Ê¯×ªÕ¨x¯e¯f¡]non-alcoholic fatty liver disease¡A²ºÙ NAFLD¡^¤¤ªº¨¤¦â¡C¦b³sÄò 12 ¶gÁý¹°ª¯×ªÕ¶¼¹«á¡A¨É¨ü°ªªo¯×¤jÀ\ªº§Ö¼Ö¤p¹«ÌÅ髬©úÅã¼W¤j¡A¹ï·Ó²Õª`¤J¤@¯ë¸¢¯f ¬r¡A¹êÅç²Õ«hª`¤J±a¦³ TRABID °ò¦]ªº¸¢¯f¬r¡AÄ~ÄòÆ[¹î 4 ¶g¡C 3.(2018¦~Nature¤l¥Z½×¤å)¥hªx¯À¤Æ酶USP14:该¤å§Q¥Îªx¯À¤Æ×饰组¡B³J¥Õ组¡B³J¥Õ¤¬§@组¡A³Ì终筛选¤F¥hªx¯À¤Æ酶USP14ªº©³ª«³J¥Õ¯×ªÕ»Ä¦X¦¨酶FASN¡A¦}´¦¥Ü¤F¨ä¦b¯×ªÕ¨x发¥Í发®i¤¤ªº«n·sÉó¨î¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/15 ¤W¤È 05:05:39
²Ä 3675 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/7 ¤U¤È 12:21:09²Ä 3297 ½g¦^À³ 2023.6.30--Madrigal¤w¶}©lºu°Ê´£¥æNASH·sÃÄ¥Ó½ÐNDA-->³o¬OF2-F3ªºÃÄÃÒ!(Madrigal¥h¦~¤~¥[¶}F4Á{§É) «ö¥Ø«e¼Æ¾Ú¡A²Ä1¤ä¦b[«D¨xµw¤Æ]F2~F3»P[ ¨xµw¤Æ]F4¤jº¡³e¨úÃÒªº¬OAkeroªºEfruxifermin¾÷²v¸û¤j¡C ªYÄ£F4¥[ªo!!! -------------------------------------------------------------------------------------------
2024.3.14-FDA§åã¤FMadrigalªºMASH(F2~F3)ÃÄÃÒ! ¤£¹LF4ÃÄÃÒ(¥NÀv©Ê¨xµw¤Æ)¤~¬O³Ì¤jªºÂê÷®w! |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/3/14 ¤W¤È 09:25:45
²Ä 3674 ½g¦^À³
|
n¤H¦b¥x¥_¡A¶}ªÑªF·|ªº®É«á·F¼É¨e̳o¨Ç¤r¦ì¯ÀÀ\¨S¥ÎªºªF¦è¡C ¸Ü»¡¦^¨Ó¡A§ÚÁÙ¦³«ùªÑ¡C§Ú¤£¤]¬OSB¤@Ó «¢«¢ n¾Ç¤O´¹Áp¦X°_¨Ó¡A¶ÀÂΤ~¤£´±¦Y¬ÛÃø¬Ý¡C ³£¬O¤@½L´²¨F¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/3/14 ¤W¤È 08:44:47
²Ä 3673 ½g¦^À³
|
³o¶¡¤½¥q¼F®`ªºÂI¬O¥L̤]¨S¥´ºâ¥X¨Ó¼á²M²{¦bª¬ªp¬O«ç¼Ë~ ¦pªG¤@¶¡¤½¥q¹ïªÑªF¬O³oºØºA«×¡A¤º³¡¨î«×¦³¦h¶Ã¥i·Q¦Óª¾¡A ¤@¶¡°µÃĪ«¬ãµoªº¤½¥q¡A¦pªG«o²@µL¨î«×¡An¦p¦ó»¡ªAªÑªF¬Û«H¥L¬O¦³¥¼¨Óªº? §ó§O»¡n°ê¥~¤j¼t¨Ó¶R±ÂÅv¡A½Í¨ÖÁʧó¬OªÅ¤f»¡¥Õ¸Ü¡A ¥ú¬O¬Ý¨ì³oºØ¤½¥q°µ¨Æ±¡ºA«×´Nª¾¹D°ê»Ú¤j¼t¬°¤°»ò³£¤£·Q¨Ó½Í¦X§@¤F... ¨S¤H·|¶û¿ú¤Ó¦hµM«á©¹¤ô¸Ì¥á~ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/3/13 ¤W¤È 10:45:40
²Ä 3672 ½g¦^À³
|
2WÂI¤F¡AªÑ东±¡¦ó¥H°É¡K n¨x¤j楼¡B¨x¨ý鸡±Æ¡A³£没·N见¡CªÑɲ300´N¦n¡C 还说¤°³Q¦¬购¡A没200¡A®M©Ð还«Ü¦h¤H没ªk¸Ñ®M |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/3/13 ¤W¤È 08:46:50
²Ä 3671 ½g¦^À³
|
·|¤£·|þ¤Ñ«¥ÌªYÄ£¤]µoÓ·s»D
¬°¦]À³¬ãµo¥[³t¡A»Ýn¼x¤~ÂX½s¡A²{¦æ¿ì¤½«ÇªÅ¶¡¤£¨¬¡A¨M©w¥¸¸êX»õ»\¤j¼Ó~~
¤j¼Ó¦WºÙ => ¨xÀç¾i¤j¼Ó
ªÑªFÌ¡G!!?? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/3/12 ¤U¤È 08:08:19
²Ä 3670 ½g¦^À³
|
³Í³Í¤§¦º¡þ´¿®½1200¸Uµ¹¨àºÖÁp·ù¡@¥L¨£hµ£®×ÅF¡u§O¦A¦¬®½´ÚÄF·R¤ß¡v¡@¶æÁp·ù¨C¤Ñ¥´²V»âÁ~ ¦P²z¥iµý¡Aª©¤W§Ṳ́]®½¤F¤£¤Öµ¹ªYÃÄ¡A¤]¥i¥H¶æ¤½¥q¨C¤Ñ¥´²V»âÁ~ ¤S¬O¤@Ó°ê³»¡A¤½¥q¤£ºt¤F ============================================================
·|û¡GStockMaster10153183 µoªí®É¶¡:2024/3/12 ¤W¤È 08:20:58²Ä 3668 ½g¦^À³ ³oºØ¸Üè¶}©l«Ü»¤´b¤H¡A¦ý»¡¤F³o»ò¤[¦A¬Ý¬Ý¤½¥q§@¬°...... ²{¦b¬Ý¨ì¥u·|ı±o¦³ºØ¦Û´Û´Û¤Hªº²Y²D·P...... ¤£¹L¤H¥ÍÁ`¬On¦³¹Ú¡A¥u¬O¨CÓ¤H¿ôªº®ÉÔ¤£¤@¼Ë....
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G½²ºû¤¯10143700 |
µoªí®É¶¡:2024/3/12 ¤U¤È 02:02:13
²Ä 3669 ½g¦^À³
|
ªYÄ£§ë¸ên¦AÓ5¦~®É¶¡¤~¯à¦³¸û¦nªºªÑ»ù¡I¤pªÑªF±z·þ«P¬½½|¤½¥q¡A¨¬°¤p¤pªÑªF§Ú¼ÖÆ[¤§¡A§Æ±æ¤½¥q¯à¥[§Ö¸}¨B¡IµL½×¬ãµo©Î½Í±ÂÅv¡CÓ¤H§ë¸ê3¦~¤F¡A¤@¤ò¿ú¤]¨SÁȨì¡FÁÙ¬O¦³«H¤ßªYÄ£¥¼¨Óµo®i¡A¤j®a¥[ªo¡I |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/3/12 ¤W¤È 08:20:58
²Ä 3668 ½g¦^À³
|
³oºØ¸Üè¶}©l«Ü»¤´b¤H¡A¦ý»¡¤F³o»ò¤[¦A¬Ý¬Ý¤½¥q§@¬°...... ²{¦b¬Ý¨ì¥u·|ı±o¦³ºØ¦Û´Û´Û¤Hªº²Y²D·P...... ¤£¹L¤H¥ÍÁ`¬On¦³¹Ú¡A¥u¬O¨CÓ¤H¿ôªº®ÉÔ¤£¤@¼Ë.... ¦³ªº¤H¥i¯à¤@ª½¨ì¦Ñ¦º³£¨S¦³¿ô~ n¬O¯un¨ì±ÂÅv¶¥¬q¤F¡A·|¨S·Án? ·|¨S¤H¶R? ¿ô¿ô§a! ½Önªá¿ú¶RªYÄ£? ¤£¹L¬O¦P¾Ç·|¦Û¶Ù½}¤F~~ ¤£µM§Ú¤]¨Óµû¦ôªYÄ£§Y±N¦¨¬°¨xÃĬɪºÀsÀY¥¨À¼¡AªÑ»ù¤W¬Ý10000!!! ¶R¤F§Y±N°]´I¦Û¥Ñ¡A¤j®a§Ö±ô«¢¨®a!!! ¤U¤@Ó¥xÆW¤Úµá¯S´N¬O§A!
>>>>>>>>>>>>>>>> ªYÄ£8¨t2ÁûÃĦò¤ß»ù±ÂÅv5»õ¬ü¤¸¡A¥i¯à¬ðµM´N¨Ó¡I¦X²zªÑ»ù1000¤¸¡F6¨t2ÁûÃĤ]¹F±ÂÅv¶¥¬q¡A15»õ¬ü¤¸¦X²z¡AªÑ»ù¦X²z´Á«Ý4000¤¸¡CÃz®Æ¦P¾Ç·|¦³¤Hµû¦ôªYÄ£¥i¯à³Q¶R¨«¡I´²¤á§ë¸ê´N¬O·QÁÈ¿ú¡I°¨¤W¼Æ¶r²¼¤]¬O¤Ñ¤jªº¦n¡Iª¾µL¤£¨¥¤j®a·í°Ñ¦Ò´N¦n¡C
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G½²ºû¤¯10143700 |
µoªí®É¶¡:2024/3/9 ¤U¤È 12:28:56
²Ä 3667 ½g¦^À³
|
ªYÄ£8¨t2ÁûÃĦò¤ß»ù±ÂÅv5»õ¬ü¤¸¡A¥i¯à¬ðµM´N¨Ó¡I¦X²zªÑ»ù1000¤¸¡F6¨t2ÁûÃĤ]¹F±ÂÅv¶¥¬q¡A15»õ¬ü¤¸¦X²z¡AªÑ»ù¦X²z´Á«Ý4000¤¸¡CÃz®Æ¦P¾Ç·|¦³¤Hµû¦ôªYÄ£¥i¯à³Q¶R¨«¡I´²¤á§ë¸ê´N¬O·QÁÈ¿ú¡I°¨¤W¼Æ¶r²¼¤]¬O¤Ñ¤jªº¦n¡Iª¾µL¤£¨¥¤j®a·í°Ñ¦Ò´N¦n¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/9 ¤W¤È 10:50:02
²Ä 3666 ½g¦^À³
|
MadrigalªºResmetirom±N®³¨ì²Ä1¤äMASH(F1~F3)ÃÄÃÒ? ¤U¶g´¦¾å! |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/9 ¤W¤È 10:11:13
²Ä 3665 ½g¦^À³
|
Akero¦b2024.3.4¤½¥¬ªº(F1~F3)96¶gÁ{§É¼Æ¾Ú«GÂI: À»±Ñ§¨Ó¦b2024.2.7¤½¥¬ªºGIP/GLP-1ÃĪ«¼Æ¾Ú¡AEfruxifermin¬O¥Ø«e³Ì°ªªºMASH±wªÌÀ³µª²v75%¡C ¥t¥~§¨Ó¨S¦³¤½¥¬ÅÖºû¤Æ§ïµ½¼Æ¾Ú!!!
Áô¼~:¤J²Õ128¦W¡A¦@³ø§i¤F15¨ÒÄY«¤£¨}¨Æ¥ó¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/3/9 ¤W¤È 09:42:28
²Ä 3664 ½g¦^À³
|
©µªøF1~F3ªvÀø´Á¡AM(52¶g)»PA(96¶g)³£©úÅã±a¨Ó§ó¦nªºµ²ªG! Akero±N¦b2025Q1¤½¥¬F4±wªÌ96¶gªvÀøµ²ªG.
2024.3.4--www.statnews.com/2024/03/04/mash-liver-scarring-akero-efruxifermin/ Akero Therapeutics ¶g¤@ªí¥Ü¡A±N¨äªvÀø¨x¯fMASH ªº¹êÅçÃĪ«ªºªvÀø±q¤»Ó¤ë©µªø¦Ü¨â¦~¡A¬°±wªÌ±a¨Ó¤F§ó¦nªºµ² ªG¡A³ÌÅãµÛªº¬O¡A¨xŦ¬Í²ªªº´î¤Ö³t«×¤ñ¦w¼¢¾¯°ª¥X¤T¿¡A¨ä¥L¯gª¬¨S¦³´c¤Æ¡C
(§Úµû:¦@³ø§i¤F15¨ÒÄY«¤£¨}¨Æ¥ó¡A¨S¬Ý¨ìAkero»¡©ú¡A¦³Áô¼~!) --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/7 ¤U¤È 12:11:15²Ä 3296 ½g¦^À³ ...MadrigalªºResmetirom¦bNASH P2(36¶g)ªºÁ{§Éµ²ªG¡AÅÖºû¤Æªº§ïµ½¬O¨S¦³²Îp¾Ç·N¸q! Resmetirom¤T´Á临§É设计¤¤¡AMadrigal°µ¹ï¤F¤°»ò¡H ...µ²½×:调¾ã¤F¨x纤维¤Æ««×±wªÌªº¤ñ¨Ò+ ¥[ªøªvÀø´Á (¤G´ÁªvÀø´Á 36¶g ¡A¤T´ÁªvÀø´Á 52¶g¦³²Îp¾Ç·N¸q)¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/3/8 ¤W¤È 08:34:16
²Ä 3663 ½g¦^À³
|
¬Y¨Ç±Mªù§j³o¶¡¤½¥qªº¤H¤]¶V¨Ó¶V¤Öµo¤å¤F~ ¦ôp¬O¤â¤WªÑ²¼³£¥X²M¤F§a~ «Ü¦n©_³o¶¡¤½¥qû¤u¤W¯Z³£¦b°µÔ£?
¬Ý¼v¤ùª±¤â¹C=> 5¤p®É ¤ÈÀ\¤È¥ð => 1¤p®É q¤U¤È¯ù¦Y¤U¤È¯ù => 1¤p®É ´Z©Ò©ñªÅ => 30¤ÀÄÁ Â\Äê©ñªÅ³B²z¨S·N¸qªº±M§Q => 30¤ÀÄÁ
¬O³o¼Ë¶Ü?
©Ò¥H¤~·|³sµo¤å³£Ãi±oµo¡Aı±o§ë¸ê¤Hªº¿ú¦³·Ç®ÉÂରÁ~¤ô´N¦n
µM«áµ¥µÛ·ÇÂI¤U¯Z?
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/3/7 ¤U¤È 06:21:12
²Ä 3662 ½g¦^À³
|
Netflix¦³©ç¬¥¯Çªâ¡A¥s©U§£¤½¥qû¤u¥h¬Ý¬Ý¡A¤Ï¥¿¤W¯Z³£¦b¥´²V¡A·d¤£¦n³£¬Ý¹L¤F |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/3/5 ¤U¤È 02:01:27
²Ä 3661 ½g¦^À³
|
³oÀɦn¥i´d¡AºCºC¨S¤Hn½Í¤F~ ¤j·§¬O³£¹Ú¿ô¤F¡A¬Ý²M·¡¨Æ¹ê¤F~ °£¤F¦UºØ§j¹Ú¤§¥~¡A¤]¤£ª¾¹D³oÀɪѲ¼ÁٳѤUÔ£¥\¯à¡A ®M¥y²{¦b®É¶Õ¬y¦æªº¸Ü:³oÀÉ´N¬O¨ì³BóO¬y¶q¡A¦ýóO¤F¬y¶qÁÙ¬O¨S¤HnÃöª`~ ¤½¥q¤º¦h¥b³£ª¾¹D³Q½|«ÜÅ¥¡A¦ý¦³¤H¦b¥G¶Ü? ¤Ï¥¿¤½¥q¸êª÷°÷¤º³¡û¤u¾i¦Ñ¤F¡A ÃD¥~¸Ü¡A¦³¤Hª¾¹D¥LÌ¥h¦~©³§À¤ú©â¼ú¤S©â¤FÔ£¦ÛªÎ¶Ü~~
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/20 ¤W¤È 09:39:16
²Ä 3660 ½g¦^À³
|
¤H¤uÅp¥Í´¼¼z¡G¬Oµ½¡A§í©Î¬O´c¡H ¤H¤uÅp¥Í´¼¼z¬O¥Ñ¼Æ¦ìÅp¥Í(Digital Twin)¡A¦X¦¨¼Æ¾Ú (Synthetic Data)¥H¤Î¥i«H¥ô¤H¤u´¼¼z(Trustworthy Artificial Intelligence) ¥æ¤e©Ò§Î¦¨ªº·s¿³¸ê®Æ¬ì¾Ç¬ì§Þ¡A¤w¸g¥H¸§Öªº³t«×¼vÅT¬ü°ê¦Ê¤u¦Ê·~ªº¤u§@¹êªp¡C
¤H¤uÅp¥Í´¼¼z¤§[µ½]¡G¼Æ¦ìÅp¥ÍÁ{§É¸ÕÅç¡Ð¦X¦¨±±¨î²Õ ¦¹¶µ§Þ³N¬Oªñ´Á©ó¬ü°êÂåÃĬɳvº¥¼öªùªºÁ{§ÉÂå¾Ç·s½d¦¡¡C¨äì²z¬O§Q¥Î¤H¤u´¼¼z§Þ³N¡A½Æ»s¼ÒÀÀ¥X±wªÌªº¼Æ¦ìÅp¥Í(Digital twin)¡C¦Ó¼Æ¦ìÅp¥Í±wªÌ¥i¥Î©óªvÀøÃĪ«ªºÁ{§É¸ÕÅ礤¡A±±¨î²Õªº¼ÒÀÀ¡A¥H¥[³tÃĪ«¸ÕÅ窺¾ãÅé¬yµ{¡AÅý±wªÌ¦¤é¨Ï¥Î³Ì·sÂå¾Ç¦¨ªGªºµ²´¹¡Cwww.ntsec.edu.tw/liveSupply/detail.aspx?a=6829&cat=6843&p=1&lid=19248&print=1 |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/20 ¤W¤È 09:33:23
²Ä 3659 ½g¦^À³
|
¼Æ¦ìÅp¥Í(Digital Twins) + AI ªº®É¥N§Y±N¨ÓÁ{¡I½÷¹F³Ð¿ì¤H¶À¤¯¾±ªí¥Ü¡K |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/20 ¤W¤È 09:22:10
²Ä 3658 ½g¦^À³
|
¨xŦDT®i¥Ü¤F¥Íª«¤O¾Ç©M²ÓM°Ê¤O¾Ç¤§¶¡ªº¬Û¤¬§@¥Î¡A¥i¥H¸ÑÄÀÅÖºû¤Æ½I²ª§Î¦¨ªºì¦] DT¹w´ú¨x¹jÅÖºû¤Æ¬O¥Ñ CYP2E1 ªí¹F²ÓM¡]DAMPs ·l¶Ë¬ÛÃö¤À¤l¼Ò¦¡ªº¨Ó·½¡^ªº®ÉªÅ¤À§G©ÒÅX°Ê ----------------------------------------------------------------------------------------
MASHªºÃĪ«¬ãµo¤w¸g¶i¦æ¤F¼Æ¤Q¦~¡A¬°¦ó[¤@ÃÄ]µL¦¨? ¦ý¥Ñ©óMASHµo¯f¾÷¨î¤£©ú¡B¯Ê¥F¾A·íªº°Êª«¼Ò«¬¡A¨Ï±o¤j¶qªº·sÃĬãµopµe¤î¨B©óÁ{§É¶}µo¶¥¬q¡C ¦]¦¹¡A«Øºc²z·Qªº°Êª«¼Ò«¬¬O¸Ñ¨MMAFLD/MASH«Â¯Ùªº«n¬D¾Ô»PÃöÁäÀô¸`¡A¹ïMASH·sÃÄÂà¤Æ¨ã¦³«nªº·N¸q¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/20 ¤W¤È 09:04:36
²Ä 3657 ½g¦^À³
|
1.2019--³sÄò¤T¦~³Qµû¬°¥þ²y¤Q¤j¬ì§ÞÁͶժº¡u¼Æ¦ìÅp¥Í¡v¨ì©³¬O¤°»ò¡H(¤W) ...²³æ¨Ó»¡¡A(Digital Twin)¼Æ¦ìÅp¥Í¬O«ü³z¹L¦s¦b©óµêÀÀ¥@¬Éªº¡uÂùML¡v¡A¨ÓÅã¥Ü²{¹ê¥@¬É¤¤ªºª«Åé¥i¯àªº¤ÏÀ³¡B ª¬ªp©Î¬O®Ä¯àµ¥¡C
2.2023(ªk°ê°ê®a¼Æ¦ì¬ì¾Ç»P§Þ³N¬ã¨s©Ò)- A digital liver twin demonstrating the interplay between biomechanics and cell kinetics can explain fibrotic scarformation (¨xŦDT®i¥Ü¤F¥Íª«¤O¾Ç©M²ÓM°Ê¤O¾Ç¤§¶¡ªº¬Û¤¬§@¥Î¡A¥i¥H¸ÑÄÀÅÖºû¤Æ½I²ª§Î¦¨ªºì¦]) hal.science/hal-04211418/file/LiverFibrosisManuscript.pdf .... ....µ²½×¡GDT¹w´ú¨x¹jÅÖºû¤Æ¬O¥Ñ CYP2E1 ªí¹F²ÓM¡]DAMPs ·l¶Ë¬ÛÃö¤À¤l¼Ò¦¡ªº¨Ó·½¡^ªº®ÉªÅ¤À§G©ÒÅX°Ê¡A¨Ã¥Ñ¨x²ÓM¼W´Þ§Î¦¨¡C DT¥i¥HÂX®i¨ì¬ã¨s±q±ß´Á¨xÅÖºû¤Æ©Î¨xµw¤Æ¨ì¨xÀùªºÂàÅÜ¡C
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/2/20 ¤W¤È 08:39:30
²Ä 3656 ½g¦^À³
|
¾ã¤Ñ³£¦b»¡SNP610¤ñ½Ö®ÄªG¦n¡BSNP610Îx¥´½Ö½Ö½Ö
µ²ªG....¨º¨Ç³QSNPÎx¥´ªºªF¦èÓÓ³£½æ¥X¤Ñ»ù±ÂÅvª÷
µM«áSNP610ÁÙ¬O¤@¼Ë¥F¤H°Ý¬z~
¯u¦³¨º»ò¼F®`¡A¤j¼tÌÃø¹D³£¬O¥Õè¶Ü?¹çÄ@ªá¤j¿ú¥h¶R³QSNP610Îx¥´ªºªF¦è....?
Á¿¥Õ¤F¡A¤@©w¬O¦³P©Rªºµw¶Ë¦s¦b¡A¦Ó¥B¨S¤½§G¥X¨Ó¡A¨å«¬ªº³ø³ß¤£³ø¼~~
³o¶¡¤½¥q¤½§iªº¦UÀô¸`®É¶¡¤]¬O¹³¤§«e³Q¤j®a«õ¥X¨Óªº¤@¼Ë¡A³£¹ï¤£°_¨Ó¡A
¹ï³o¶¡¤½¥qªº¸Û«H¶V¨Ó¶VÃhºÃ......
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/19 ¤U¤È 12:52:55
²Ä 3655 ½g¦^À³
|
2024.2.12- 43»õ¬ü¤¸¡I ¦N§Q¼w¦¬ÁÊCymabay Therapeutics(´N1¤äSeladelpar¦b¬ã¤fªAPPAR£_ªvÀøPBCÃĪ«) www.gilead.com/news-and-press/press-room/press-releases/2024/2/gilead-sciences-expands-liver-portfolio-with-acquisition-of-cymabay-therapeutics
------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/25 ¤W¤È 09:19:37²Ä 2540 ½g¦^À³ SNP-610Àu©óElafibranor (PPAR£\/£_¿E动剂) Genfit»PIpsen (¶R¤U´¼Àº¯ØŦÀùÃĪ«)¦b2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç
VS. ¥¿¤j¤Ñ´¸ªá3.07»õ¬ü¤¸ªº[PPAR]¿E动剂Lanifibranor ¡A¥i¿E¬¡PPARªº¥þ³¡3Ïú亚«¬£\¡B£^¡B£_¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMaster10153183 |
µoªí®É¶¡:2024/2/19 ¤W¤È 09:17:08
²Ä 3654 ½g¦^À³
|
«¤j¶i®i!!!!
èèµL·N¶¡ÂI¶}ªYÄ£©xºô!!!!
µ²ªGµo²{.......
ªYÄ£©xºôªººô¶UI´«¤F¡AÅܦn¬Ý¤F¡Aì¨Ó§ë¸ê¤Hªº´X»õ¤¸³£¬O®³¨Ó§@©xºô¬ü¤u¤F§r~
³oºØ¬ü¤u¥~¥]¦n¹³2.3¸U´N¥i¥H§¹¦¨ªºªF¦è....
¨ä¥¦¿ú¶]¥hþ¤F?û¤uÁ~¤ô¡B©xºô¬ü¤u....ÁÙ¦³¤°»ò©O?
§À¤ú©â¼ú¶Ü? û¤u®È¹C¶Ü?
n©â¼ú·íµM¥i¥H! n®È¹C·íµM¥i¥H! n»â°ªÁ~·íµM¥i¥H!
¦ý¦Ü¤Ö°µ¥XÂI¦¨ÁZ¨Ó¡A¤£µM¯uªº³£¬O®³§ë¸ê¤Hªº¿ú¦b¦ÛªÎ~
¦³°÷¸Ø±i!
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/19 ¤W¤È 08:47:13
²Ä 3653 ½g¦^À³
|
2023¦~¾P°âÃB 1.Àq¨FªFKeytruda: 250»õ¬ü¤¸(2021¦~171.86»õ¬ü¤¸/2022¦~209»õ¬ü¤¸) 2.¿Õ©M¿Õ¼wGLP-1ÃÄ:211.4»õ¬ü¤¸(2021¦~55»õ¬ü¤¸ / 2022¦~109»õ¬ü¤¸) 3.«e¥ô¡uÃĤý¡vHumira:144»õ¬ü¤¸ ----------------------------------------------------------------
¿Õ©M¿Õ¼wGLP-1ÃÄ¡A¦b2021¦~®³¨ì´îªÎ¯g«áªº¾P°â¦¨ªø²§±`¸Ø±i!!! n¤£¬O¨ü©ó²£¯à ©Î³\2023¦~§Y¦¨·s¥ôÃĤý |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/2/18 ¤U¤È 10:07:14
²Ä 3652 ½g¦^À³
|
R¤j¤£·íMARKET¤Ó¥i±¤¤F¡A¤½¥q¤]»Ýn§A¡A§ÚÌ©`¦Ì¤á¤]»Ýn§A À³¥Î±¤Ó¦h¤F¡A¥ý¨Ó«O°·«~¦Y¦Y ¤£µM¥«³õ¬£¤Ó¦h§Q¦h¥i¥Hª£ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/18 ¤U¤È 08:09:46
²Ä 3651 ½g¦^À³
|
2023¦~¡AÂÍÁp13¦~¡uÃĤý¡vªºHumira׬ü¼Ö¡A³QÀq¨FªFªºKeytrudaÀ½¤U¤ý®y. ¦Ó¿Õ©M¿Õ¼wªº´îªÎÃÄ¥i¯à¦b2024~205¦~À½¤UKeytruda ¡A¦¨¬°·s¥ôÃĤý!
2024.2.16-¸ë¬Â¡m¼ö»¶ºu¿S¡n±È°_´î«¼é °·¨±Ð½m¡G98¢H¤H°µ¤£¨ì ®Ú¾Ú²Îp¡AºI¦Ü2¤ë17¤é¤U¤È2ÂI¡A¬K¸`Àɹq¼v¥H¤j³°¤kºtû¸ë¬Â¥DºtªºÂ½©ç¹q¼v¡m¼ö»¶ºu¿S¡n»â¶]¡A²Öp²¼©Ð¤w¦³¤H¥Á¹ô26.63»õ¤¸¡A¶W¶V2023¦~±iÃÀ¿Ñ°õ¾Éªº¡mº¡¦¿¬õ¡n¡A¨ê·s¼v¥v¬K¸`Àɼ@±¡¤ùÀÉ´Á²¼©Ð¬ö¿ý¡C
---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/9/5 ¤U¤È 03:56:04²Ä 3439 ½g¦^À³ ´îªÎÃÄ·í¹D¡I1.§¨Ó¥«È5288»õ¬ü¤¸ 2.¿Õ©M¿Õ¼w¥«È4236»õ¬ü¤¸ 3.JNJ ¥«È4170»õ¬ü¤¸ -------------------------------------------------------------------------------------------- 2023.8.19---¿}§¿¯f°w¾¯¥Î©ó´îªÎ ¬ü°ê§¨ÓÃļt¥«È¶W¶V¥x¿n¹q |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/14 ¤U¤È 03:26:11
²Ä 3650 ½g¦^À³
|
SNP-810-->¼³¼ö®§µh(°²´À£)+¤T´â½©¿}(§ÜVEGF)+¥ÌÅS¾J «C¥ú²´¬O导P¥¢©úªº¥Dnì¦]¤§¤@¡A¥Ø«e©|ÆÓªv·U¤èªk---ªYÄ£SNP-810¤£§@«C¥ú²´°Êª«¹êÅç¬ã¨s¬ã¨s? (¹p¯]³æ§Ü¬OªvÀø«C¥ú²´«½SÃĪ«¡A2021¦~¥þ²y¦¬¤J¬ù34»õ¬ü¤¸)
2013.1.30-¤fªA¼³¼ö®§µhªº°²´À£§@¥Î¤Î¨äÅé¥~¨¤½¤¬ï³z¯S©Ê www.ncbi.nlm.nih.gov/pmc/articles/PMC3564461/ ¦´Á«C¥ú²´±wªÌ¨CÃB¥~°§C 1 mmHg ²´À£¡A«C¥ú²´¶i®iªº·ÀI´N·|°§C¬ù 10%¡C ...¬ã¨sªºµ²ªGªí©ú¡A¨C6 ¤p®É¤fªA1 g ¹ï¤AñQ®ò°ò×ô¡A¥i¥H°§C¶}¨¤«¬«C¥ú²´©M/©Î©Ð¨¤«á°h«¬«C¥ú²´±wªÌªº²´¤ºÀ£¡A¨ä®ÄªG»P¥Ø«e¥i¥Îªº¨ä¥L´XºØ°²´À£ÃĪ«¬Û·í¡C
------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/8 ¤U¤È 07:13:29²Ä 3615 ½g¦^À³ ¤T´â½©¿}¥i¯à¨ã¦³§Ü VEGF ªº¼ç¤O-->¤]¥i¯à¥Î©ó·s¥Í¦åºÞ©Ê[«C¥ú²´]ªvÀø??? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/11 ¤U¤È 04:56:52
²Ä 3649 ½g¦^À³
|
¦w¥þ°_¨£¡A24¤p®É¤ºªA¥ÎAPAP³Ì¦n¤£n¶W¹L3§J!
www.medicaid.nv.gov/Downloads/provider/web_announcement_468_20120425.pdf April 25, 2012 Announcement 468 FDA Acetaminophen Dosage Announcement On January 13, 2011, the U.S. Food and Drug Administration (FDA) announced new measures to reduce the risk of severe liver injury associated with acetaminophen. On July 28, 2011, the maker of Tylenol®, McNeil, announced new instructions to lower the maximum daily dose from 4,000 mg to 3,000 mg. -------------------------------------------------------------------------------------------- 2012¦~4¤ë25¤é²Ä468¸¹¤½§i FDA ¹ï¤AñQ®ò°ò×ô¾¯¶q¤½§i 2011¦~1¤ë13¤é¡A¬ü°ê¹«~ÃĪ«ºÞ²z§½¡]FDA¡^«Å¥¬¤F·s±¹¬I¡A¥H´î¤Ö»P¹ï¤AñQ®ò°ò×ô¬ÛÃöªºÄY«¨x·l¶Ëªº·ÀI¡C 2011 ¦~ 7 ¤ë 28 ¤é¡ATylenol® ªº»s³y°Ó McNeil¡A«Å¥¬·sªº»¡©ú¡A±N¨C¤é³Ì¤j¾¯¶q±q 4,000 ²@§J°§C¦Ü 3,000 ²@§J¡C ----------------------------------
4g§ï3g¤£¬O¤@¶µ±j¨î©Ê³W©w! ¥u¬O¬°¤F§ó¦w¥þªº¨Ï¥ÎAPAP |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/10 ¤U¤È 03:51:12
²Ä 3648 ½g¦^À³
|
4-8g SNP-810 VS. 4g APAP
ªYÄ£µL¨x¬r¤îµh·sÃÄSNP-810(8§J)¤§Á{§É¸ÕÅçµ²ªG ¥Dn«ü¼Ð¡G¦U²ÕALT®pÈ»Pµ¹ÃÄ«e¤§°ò¦Ȭۤñ¤§¦Ê¤À¤ñµL²Îp¤WÅãµÛ®t²§¡Aªí¥Ü¨Ï¥ÎSNP-810¨ä¤AñQÓi×ô¾¯¶q¨C¤Ñ4-8§J(¬°¹L¥h®Öã¤W¨C¤Ñ4§Jªº2¿)§¡¥¼²£¥Í¨x¬r©Ê¡C¦¸n«ü¼Ð¡G¦U²Õ¦bALT®pȧ¡¥¼¶W¹L2¿¥¿±`È¡A§YALT¤É°ª¤j©ó2~8¿¥¿±`ȤW¤§¤ñ¨Ò¬°0%¡C
VS. 2006.7.5--°·±d¦¨¤H¨C¤Ñ±µ¨ü(4§J)¹ï¤AñQ®ò°ò×ôªºÂà®ò酶¤É°ªÀH¾÷¹ï·Ó¸ÕÅç jamanetwork.com/journals/jama/fullarticle/211014
µ²ªG:±µ¨ü¦w¼¢¾¯ªvÀøªº 39 ¦W°Ñ»PªÌ¤¤¡A¨S¦³¤@¤Hªº³Ì°ª ALT ȶW¹L¥¿±`¤Wªº 3 ¿¡C¬Û¸û¤§¤U¡A¦b±µ¨ü¹ï¤AñQ®ò°ò×ôªvÀøªº 4 ÓªvÀø²Õ¤¤¡A¥]¬A³æ¿W±µ¨ü¹ï¤AñQ®ò°ò×ôªvÀøªº°Ñ»PªÌ¡A³Ì¤j ALT ¶W¹L¥¿±`¤W3¿ªºµo¥Í²v¬° 31% ¦Ü 44%¡C»P¦w¼¢¾¯¬Û¤ñ¡A¹ï¤AñQ®ò°ò×ôªvÀø»PÅãµÛ¸û°ªªº¤¤¦ì¼Æ³Ì¤j ALT ¬ÛÃö¡]¤¤¦ì¼Æ¤ñ¡A2.78¡F95% ¸m«H°Ï¶¡¡A1.47-4.09¡FP <.001¡^¡C -------------------------------------------------------------------------------------------------
¨C¤Ñ¤fªA 4 §J¹ï¤AñQ®ò°ò×ôªº 106 ¦W±wªÌ¤¤¡A¦³ 81 ¦W (76%) ªºALT¤ô¥¦Ü¤Ö¤É°ª¨ì¥¿±`¤W ( ULN) ¥H¤W¡]§Y>40 U/L¡^¡F53% ªº ALT ¤ô·Ç®pȤj©ó 2 ¿ ULN (>80 U/L)¡A39% ¤j©ó 3 ¿ (>120 U/L)¡A25% ¤j©ó 5 ¿ (>200 U/L)¡A8 % ¤j©ó8 ¿( >320 U/L)¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/1 ¤U¤È 01:23:32
²Ä 3647 ½g¦^À³
|
ª`·N¨ì¤K¦WºC©Ê¯kµh¯gÔ¸s±wªÌ±µ¨ü°ª¾¯¶q AAPªvÀø±ß´ÁÀù¯g®É¥i¹F¨ì [12-24]¤p®Éªº§¹¥þÂíµh(ÃĤO²¤Àu¾~¤ùÃþ[ªø®Ä«¬]¤îµhÃÄ?) ---------------------------------------------------------------------------------------------------
1. 19 ¦W±ß´ÁÀù¯g±wªÌ¶i¦æ¤F°ª¾¯¶q¹ï¤AñQ®ò°ò×ôÁp¦XNAC±Ï´©ªº¸ÕÅç(8/19=42%) 2.²¸»Ä¶Ü°Øªø®Ä¿õ:¬°¸Ñ°£Àù¯g¥½´Á¯f¤H¤§ÄY«¯kµh¦Ó¯S§O³]p¤§ªø®Ä«¬¤îµhÃÄ¡A¨C¤Q¤G¤p®ÉªA¥Î¤@¦¸¡A§ëÃĤ覡²©ö¡A¹ïÀù¯g ¥½´Á±wªÌ©~®aªvÀø¬Û·í¦X¾A¡C
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/1 ¤U¤È 12:40:30
²Ä 3646 ½g¦^À³
|
°ª¾¯¶q¹ï¤AñQ®ò°ò×ôªvÀø [Àù¯g¥½´Á] ±wªÌ¨ã¤îµh®ÄªG! °ª¾¯¶qAPAPÂíµh®ÄªG§ó¦n¡A¯à·m¥e¾~¤ùÃþ¤îµh¥«³õ.
---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/15 ¤U¤È 11:43:30²Ä 1707 ½g¦^À³ ¦]¬°¬ü°êFDA¤w¹ï(¤j§Å)¾~¤ùÃþ¤îµhÃĪ«¶}îÔ¡A(¤p§Å)APAPÃĪ«¥«³õ¥²±N¥ÑµäÁY«¦^¦¨ªø>40»õ¬ü¤¸! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 10:26:06²Ä 700 ½g¦^À³ ¦]¬°¾Ö¦³§O¤H¸ó¤£¹Lªº325mg½Æ¤è»ÙêªùÂe¡AAPAP§t¶q´£°ª>325mg/500mg¬Æ¦Ü§ó°ª(®ÄªG§ó¦n)!!! ´N¯à¦A·m¦^³QNSAIDªü´µ¤ÇÆF /Opioidsªü¤ùÃĪ««I»kªº¥«³õ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/2/1 ¤W¤È 09:37:39
²Ä 3645 ½g¦^À³
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/1 ¤W¤È 08:44:57
²Ä 3644 ½g¦^À³
|
°ª¾¯¶q(40g)¹ï¤AñQ®ò°ò×ôªvÀø [Àù¯g¥½´Á] ±wªÌݨã¤îµh®ÄªG! ------------------------------------------------------------
°ª¾¯¶q(«ü¤j©ó4g¦w¥þ¾¯¶q)¹ï¤AñQ®ò°ò×ô¤îµh®ÄªG§ó¨Î(¦pÀYµh¡B¸gµh¡B¦Ù¦×µh¡B·Àãµh¡B¯«¸gµhµ¥»´«×¡B¤¤«×¯kµh)!? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/2/1 ¤W¤È 08:21:08
²Ä 3643 ½g¦^À³
|
°ª¾¯¶q¹ï¤AñQ®ò°ò×ôªvÀøÀù¯g¥½´Á±wªÌݨã¤îµh®ÄªG!
2024.1.31-www.mdpi.com/2673-4389/4/1/7 °ª¾¯¶q AAP Á{§É¸ÕÅ祼¸Ñµªªº°ÝÃD 1)AAP ¬O§_³z¹L®ø¯Ó GSH ¨ã¦³±þ¸~½F¬¡©Ê¡A§YÃþ¦ü©ó¨xŦ¬r©Ê¾÷¨î¡A¦pªG¨S¦³¡A¨ä¾÷¨î¬°¦ó¡H (2)¬O§_¦³¥i¯à¿ï¾Ü©Ê¦a®¾±Ï¥¿±`¨xŦ¦Ó¤£®¾±Ï¤j¾¯¶qAAPªº±þ½F§@¥Î¡H (3)¤¹³\ AAP ¦w¥þ¾¯¶q¼W¥[¦Ü§Ü¸~½F¥\®Ä©Ò»Ý¤ô·Çªº³Ì¨Î±Ï´©¤è®×¬O¤°»ò¡H³æ¿W¨Ï¥Î NAC ¯uªº¬O³Ì¨Î±Ï´©µ¦²¤¡AÁÙ¬O¨ä¥L ÃĪ«/ÃĪ«²Õ¦X§ó¦³®Ä¡H
°ª¾¯¶q AAP ªº¼ç¤O¤£¶È¨ã¦³§ÜÀù¬¡©Ê¡A¦Ó¥B¦³§U©ó¦³®ÄªºÂíµh±±¨î¡A³o¥i¯à¬O§Ṳ́èªkªº¤@Ó¤Þ¤Hª`¥ØªºÃB¥~¦n³B¡C¬ì¥¬ªL´µ°òµ¥¤H¡Cª`·N¨ì¤K¦WºC©Ê¯kµh¯gÔ¸s±wªÌ±µ¨ü°ª¾¯¶q AAPªvÀø±ß´ÁÀù¯g®É¥i¹F¨ì12-24 ¤p®Éªº§¹¥þÂíµh CYP2E1§í¨î¾¯¥ÒýmÐü¤£¤Ó¥i¯à´î»´AAPªºÂíµh§@¥Î¡A¦Ó°ª¾¯¶qAAP¦X¨Ö¥ÒýmÐü±Ï´©¥i¯à¬O¤@ºØ¦³®Äªº¤îµhÂû§À°s¡A¥i¥HÁקK³Â¾KÃĪº¬r©Ê¡A¦p«K¯µ¡B©I§l§í¨î©M³Ì²×ªº¨Ì¿à©Ê¡C¶i¤@¨B¬ã¨s°ª¾¯¶q AAP »P°ò©ó¥ÒýmÐüªº±Ï´©ªºÂíµh®ÄªG»Ýn¦b°Êª«©M¤HÅé¬ã¨s¤¤¶i¦æ¸Ô²Óµû¦ô¡C ----------------------------------------------------------------------------------
[³æ¿W¨Ï¥Î NAC ¯uªº¬O³Ì¨Î±Ï´©µ¦²¤¡AÁÙ¬O¨ä¥LÃĪ«/ÃĪ«²Õ¦X§ó¦³®Ä¡H]->¤fªA(SNP-820)TYNADOTE®+NAC ? [³æ¿W¨Ï¥Î NAC ¯uªº¬O³Ì¨Î±Ï´©µ¦²¤¡AÁÙ¬O¨ä¥LÃĪ«/ÃĪ«²Õ¦X§ó¦³®Ä¡H]->¤fªA(SNP-820)TYNADOTE®+NAC ? [³æ¿W¨Ï¥Î NAC ¯uªº¬O³Ì¨Î±Ï´©µ¦²¤¡AÁÙ¬O¨ä¥LÃĪ«/ÃĪ«²Õ¦X§ó¦³®Ä¡H]->¤fªA(SNP-820)TYNADOTE®+NAC ?classic.clinicaltrials.gov/ct2/show/NCT05557448?term=Sinew+Pharma&draw=2&rank=4 |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/31 ¤U¤È 09:47:51
²Ä 3642 ½g¦^À³
|
www.sinewpharma.com/Upload/202312/news_2023122509330608.pdf MOA of SNP-630 and SNP-610 in NASH SNP-6 can tackle multiple pathways impacting the pathogenesis of NASH1, ¼g¤JLPS-TLR4? ------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/8 ¤W¤È 10:20:54²Ä 3376 ½g¦^À³ 将¥ÑHiAlc Kpn¤Þ°_ªº[«D°sºë]©Ê¯×ªÕ¨xNAFLD©R¦W为[内·½©Ê°sºë]©Ê¯×ªÕ¨x--³oÀ³¸Ó¬Oµ¹SNP-6ÃĪ«¥[¤À!
1.¦´Á¨x·l¶ËªºÃöÁä¨BÆJ:ªø´Á±µÄ²°sºë·|·l®`¸zÖß½¤ªº«Ì»Ù¥\¯à¡A±q¦Ó¼W¥[¤HÃþ©M¤p¹«¦å²G¤¤ªº¯×¦hÁÞ¿@«× [LPS]...LPS¿@«×¥i«P¶i TLR4 ªº¿E¬¡¨Ã¼W±j KC ¤¤«Pª¢²ÓM¦]¤lªº²£¥Í¡C [[«ùÄòªº]] LPS ¼ÉÅS·|¾ÉP®w´¶¥±²ÓM¿E ¬¡¡A±q¦Ó²£¥Í TNF-£\ (TNF-£\ªº¿@«×¨M©w¨ä¹ï¨x·l¶Ëªº«OÅ@©Î¯}Ãa§@¥Î¡Aªí©úTNF-£\ªº§@¥Î¬O¿@«×¨Ì¿à©Êªº¡C
2.ªÍª¢§J¹p§B¤óµß¬O¸z±ìµß¬ì§J¹p§B¤óµßÄݪº¤@ºØ¡AÄÝ©ó[²Äõ¤ó³±©Êµß]¡A±ìª¬¡A¦³¤j¶qÂH©Êªº[¦hÁާΦ¨ªº²ó½¤¥]ÂÐ]¡C
3.¯×¦hÁÞ¡]LPS¡^¬O¥Ñ¯×ªÕ¤Î§tO-§Üì¡B¥~®Ö¡B¤º®Öªº¦hÁÞÂǦ@»ùÁä¬Û³s²Õ¦¨ªº¤j«¬¤À¤l¡C¯×¦hÁÞ¬O[²Äõ¤ó³±©Ê²Óµß]¥~½¤ªº ¥Dn²Õ¦¨³¡¤À¡A´£¨Ñ¨Ã«O«ù²Óµßµ²ºcªº§¹¾ã©Ê¡A«OÅ@²Óµßªº²ÓM½¤©è§Ü¬Y¨Ç¤Æ¾Çª«½èªº§ðÀ»¡C¯×¦hÁÞ¬O¤@ºØ¤º¬r¯À¡A¥i¤Þ °_±j¯P§K¬Ì¤ÏÀ³¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/2 ¤U¤È 01:24:04²Ä 3272 ½g¦^À³ ... 2.CYP2E1 ±Ò°Ê¥¨¾½²ÓMÅTÀ³¯×¦hÁÞ(LPS)¼W¥[ TNF-£\ ªº²£¥Í(¦´Á¨x·l¶ËªºÃöÁä¨BÆJ) journals.physiology.org/doi/full/10.1152/ajpgi.00383.2004 ¯S§Oȱoª`·Nªº¬O¡ATNF-£\ ªº²£¥Í»P CYP2E1 ¶Ê¤Æ¬¡©Êªº¼W¥[§eÅãµÛ¥¿¬ÛÃö¡A³o²M·¡¦aªí©ú¨ë¿Eªº TNF-£\ ²£¥Í¬O CYP2E1 ªí¹Fªºµ²ªG¡A»P§J¶©°°¼vµLÃö¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/31 ¤U¤È 09:34:38
²Ä 3641 ½g¦^À³
|
SNP-810°ª¾¯¶qµL¨x¬r¡ASNP-810¬O·s«¬STAT3§í¨î¾¯???
1. The hepatic protective effect of SNP-810 can be seen even up to 8000 mg/kg (equivalent to 90 g per 70 kg person) of AAP was given to SD rats. 2. The survival rate of AAP alone (Panadol) treated rats up to 2000 mg/kg were 17% (2/12). Various dosages of SNP- 810 (equivalent to 22~90 g for a 70 kg person) were 100 % (24 / 24 ). Thus, AAPinduced hepatic injury could be eradicated by SNP810 in SD rats ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/12/15 ¤W¤È 09:56:05²Ä 3572 ½g¦^À³ SNP-810°ª¾¯¶qµL¨x¬r!(JP»¡¦Y¾ãÅø¤]¨S¨Æ-¨º40g´N¬O¤pµæ¤@ºÐ)
1.2021.2.26-°ª¾¯¶q¹ï¤AñQ®ò°ò×ô [§í¨îSTAT3] ¨Ã¨ã¦³¦Û¥Ñ°ò¿W¥ßªº§ÜÀù·F²ÓM¬¡©Ê www.sciencedirect.com/science/article/pii/S1476558621000075?via%3Dihub ...±À¶i¦´ÁÁ{§É¸ÕÅ窺¥t¤@Ó»Ùê¬O¤fªA20 g/m2 AAP¡]¬ù40 §J¡A©Î80 ¿±j¤O¹ï¤AñQ®ò°ò×ô¡^¤£¤Á¹ê»Ú¹ê»Ú¡C AAP ª½±µ»P STAT3 µ²¦X¡A¿Ë©M¤O¦b·L¼¯º¸½d³ò¤º¡A¨Ã¥B¹ï STAT3 ¨ã¦³°ª«×¯S²§©Ê¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2023/12/28 ¤W¤È 06:24:41²Ä 3593 ½g¦^À³ STAT3§í¨î¥i¯àªvÀø²§¦ì©Ê¥Ö½§ª¢·kÄo
°ª¾¯¶qAPAP+NAC¬O·s«¬STAT3§í¨î¾¯(+NAC¬On¥h°£¨x¬r©Ê)<--->¨º»òµL¨x¬rSNP-810¬O·s«¬STAT3§í¨î¾¯??? °Êª«¹êÅç°µ¤F´Nª¾¹D. |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/31 ¤U¤È 09:30:22
²Ä 3640 ½g¦^À³
|
Charles River Laboratory Confirmed that SNP-810 is Hepatotoxicity-free www.sinewpharma.com/Upload/202312/news_2023122509330608.pdf |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/31 ¤W¤È 09:19:56
²Ä 3639 ½g¦^À³
|
³Q¤j¤j®Æ¤¤¡AªGµM¡K
================== ¬Ý·s»D¤Îºô¸ô³£¨S¤°»ò¤H¦bÃöª`¡B³ø¾É¡A´Nª¾¹D¨ä¹êªYÄ£¯uªº¬O©tªÚ¦Û½à¡I ¤£·|¥ý¥HOTC¤W¬[¦Aµ¹¤jÃļt¬I¥[ñq±ÂÅvÀ£¤O¡A ¯uªº¬O§â£¸¤â¦nµP¥´Äꪺ³Ì¨Î½d¨Ò¡I ¤µ¤Ñ£¸¨Ç¤H¬Ý¨ì§Q¦h¸õ¶i¨Ó¶R¡A©ú¤Ñ¦A½æ¥X¡Aµ²ªGªÑ»ù¤S¦^¨ììÂI¡I |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/30 ¤U¤È 11:44:13
²Ä 3638 ½g¦^À³
|
10-12g³¡¤À¸ê®Æ¥¿¦b¤ÀªR¾ã²z¤¤¡A«Ý§¹¦¨«á¡A±N¦Aµo«°T¤½§i¤Î¶i¦æ¬dÅçµn°O¼f®Ö¡C ---------------------------------------------------------------------------------------
·Qn1®Ú50cmª÷ãT¦p·N´Î¡A12gªº¼Æ¾Úµ²ªG¤½¥¬¥¿¦V¡A¥i¯à¾÷²v°ª¤@¨Ç! Åé«80kg *150mg/kg=12g (¤Ñ¥Í²§½è¤§¤H¥i¯à§]15g¤]¨S¨Æ)
¸q¤j«æ¶E PGY ¤u§@¤â¥U PGY ¤u§@¤â¥U(±`¨£¤¤¬r«æ±Ï³B²z) Acetaminophen ¤¤¬r 1.¾Ç²ß¥Ø¼Ð:¦p¦óµû¦ô Acetaminophen ¤¤¬r ¥HªA¹¾¯¶q¹w¦ô¡Ö150mg/kg |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/30 ¤U¤È 06:47:56
²Ä 3637 ½g¦^À³
|
¤µ¤Ñ³s70³£¥X¤£±¼ Ãø¹D¬O©ú¤Ñ¤~¤ÏÀ³50%? J³Õ¥X¨Ó¥[«ù¤@¤U |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G´MÄ_10151381 |
µoªí®É¶¡:2024/1/30 ¤U¤È 03:55:04
²Ä 3636 ½g¦^À³
|
¬Ý·s»D¤Îºô¸ô³£¨S¤°»ò¤H¦bÃöª`¡B³ø¾É¡A´Nª¾¹D¨ä¹êªYÄ£¯uªº¬O©tªÚ¦Û½à¡I ¤£·|¥ý¥HOTC¤W¬[¦Aµ¹¤jÃļt¬I¥[ñq±ÂÅvÀ£¤O¡A ¯uªº¬O§â£¸¤â¦nµP¥´Äꪺ³Ì¨Î½d¨Ò¡I ¤µ¤Ñ£¸¨Ç¤H¬Ý¨ì§Q¦h¸õ¶i¨Ó¶R¡A©ú¤Ñ¦A½æ¥X¡Aµ²ªGªÑ»ù¤S¦^¨ììÂI¡I |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/30 ¤U¤È 03:05:59
²Ä 3635 ½g¦^À³
|
²´¬ì¥Íª«Ãþ¦üÃĺ¥I´Ú1.7»õ¬ü¤¸!!!
2024¦~1¤ë22¤é¡A¤s¼w¤h«Å¥¬ÉOCoherus BioSciences达¦¨¦X§@¡A«eªÌ将¥H1.7亿¬ü¤¸º¥I´Ú¦¬购¦ZªÌ¥Íª«类¦ü药¹p¯]单§ÜCIMERLI.... -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/9 ¤W¤È 09:47:23²Ä 3619 ½g¦^À³ Ranibizumab¹p¯]³æ§Ü¡A°Ó«~¦WLucentis¡A¬O°ò¦]®õ§J¶}µoªºì³Ð²£«~¡A¬O¤@´Ú«½SÃĪ«¡A2021¦~¥þ²y¦¬¤J¬ù34»õ¬ü¤¸¡A¬ü°ê±M§Q©ó2020¦~6¤ë¨ì´Á¡A¼Ú¬w±M§Q±N©ó2022¦~¨ì´Á ------------------------------------------------------------------------------------------------- ....¦b³o¨Ç±w¦³µøºô½¤¯fÅܪº±wªÌ¤¤¡A«D±`»Ýn¦Ò¼{´À¥Nªº¼ç¦bªvÀø¤èªk¨Ó°§Cµøºô½¤·L¦åºÞ¨t²Îªº³q³z©Ê©M¦åºÞ¥Í¦¨¡C¦b¥»¬ã¨s¤¤¡A§ÚÌÃÒ©ú [¤T´â½©¿}]¥iªýÂ_ VEGF »¤¾Éªº³q³z©Ê©M¦åºÞ¥Í¦¨¹Lµ{¡C --------------------------------------------------------------------
¥ÌÅS¾J+¤T´â½©¿}ªýÂ_ VEGF »¤¾Éªº³q³z©Ê©M¦åºÞ¥Í¦¨¡A¥i¯àÀu©ó³æ¤è¤T´â½©¿}??? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/30 ¤W¤È 09:38:00
²Ä 3634 ½g¦^À³
|
¤]¤ÓºG¤F@@
==================== ©ú¤Ñ¬Ý¥«³õ«ç»ò¤ÏÀ³
|
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GÂæÃz10149029 |
µoªí®É¶¡:2024/1/29 ¤U¤È 05:41:14
²Ä 3633 ½g¦^À³
|
©ú¤Ñ¬Ý¥«³õ«ç»ò¤ÏÀ³
--------------------------------------------------------------------------- ¡i¤½§i¡jªYÄ£¨ú±oµL¨x¬r¤îµh·sÃÄSNP-810(¦w®õ®³¯k)°ª©ó¤¹³\¾¯¶q¨â¿(8§J)¤§Á{§É¸ÕÅçµ²ªG ¤¤¥¡ªÀ2024/01/29 17:12 ¡]¤¤¥¡ªÀ2024¦~1¤ë29¤é¹q¡^ ¤é ´Á¡G2024¦~01¤ë29¤é
¤½¥q¦WºÙ¡GªYÄ£(6634)
¥D ¦®¡G¨ú±oµL¨x¬r¤îµh·sÃÄSNP-810(¦w®õ®³¯k)°ª©ó¤¹³\¾¯¶q¨â¿(8§J)¤§Á{§É¸ÕÅçµ²ªG
µo¨¥¤H¡G¦¶³Í¥Á
»¡ ©ú¡G
1.¨Æ¹êµo¥Í¤é:113/01/29 2.¬ãµo·sÃĦWºÙ©Î¥N¸¹:¦w®õ®³¯k(SNP-810) 3.¥Î³~: ¤@¡B¥»¸ÕÅçÄݩ󥻤½¥qµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)¬dÅçµn°O «nÁ{§ÉÅçÃÒ¸ÕÅç¡A¥Øªº¤£¬O§ïÅܲ{¦æ¤AñQÓi×ôªvÀø¾AÀ³¯g©Î¨Ï¥Î¾¯¶q¡A¦Ó¬On ÃÒ¹êSNP-810Áa¨Ï¦b¹L¶q®É¤´¤£·|²£¥Í¨x¬r©Ê¡Aì©l¸ÕÅç³]p¬O¦h¾¯¶q¡B³æª¼¡B ³æ¤¤¤ß¤Î¤fªAµ¹¤©´¶®³¯k©ÎµL¨x¬r©Ê¤îµh·sÃÄSNP-810¤§Á{§É¦w¥þÅçÃÒ¸ÕÅç¡A§ë»P ¾¯¶q4-8§J(¦Xp36¤H)¡A¬°¾¯¶q¤w¶W¹L²{¦æ¤AñQÓi×ô(Acetaminophen)ÃÄ«~»¡©ú®Ñ ®Öã¨Ï¥Î¨C¤é³Ì¤j¾¯¶q¨â¿¤§Á{§É¦w¥þ©Ê¸ÕÅç¡F¥t©ó112¦~7¤ë31¤é¨ú±oTFDA®Öã ¦P·N§ë»P¾¯¶q©ñ¤j¬°12§J(·s¼W12¤H¡A¦Xp48¤H)¡A¥H´ú¸ÕSNP-810¦b¶W¹L²{¨C¤é ³Ì¤j¾¯¶q¤T¿¤§Á{§É¦w¥þ©Êµ²ªG¡C ¤G¡B²{¶¥¬q¨ú±oµL¨x¬r¤îµh·sÃÄSNP-810(¦w®õ®³¯k)°ª©ó¤¹³\¾¯¶q¨â¿(8§J)¤§ Á{§É¸ÕÅçµ²ªG³ø§i¡C 4.¹wp¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q: ¥»¸ÕÅç¤w©ó112/11/3¦¬®×§¹¦¨¡A10-12g³¡¤À¸ê®Æ¥¿¦b¤ÀªR¾ã²z¤¤¡A«Ý§¹¦¨«á¡A ±N¦Aµo«°T¤½§i¤Î¶i¦æ¬dÅçµn°O¼f®Ö¡C 5.¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q(½Ð»¡©ú¥Ø«e¤§¬ãµo¶¥¬q«YÄÝ´£¥X¥Ó½Ð/³q¹L®Öã/¤£³q¹L®Öã ¡AY¥¼³q¹LªÌ¡A½Ð»¡©ú¤½¥q©Ò±Á{¤§·ÀI¤Î¦]À³±¹¬I¡F¥t½Ð»¡©ú¥¼¨Ó¸gÀç¤è¦V¤Î ¤w§ë¤J²Ö¿n¬ãµo¶O¥Î): (1)´£¥X¥Ó½Ð/³q¹L®Öã/¤£³q¹L®Öã/¦U´Á¤HÅé¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG/µo¥Í¨ä¥L¼vÅT ·sÃĬãµo¤§«¤j¨Æ¥ó¡G ¤@¡B¥»¸ÕÅç¨Ìpµe®Ñ°õ¦æ§¹§ë»P¾¯¶q4-8§J¤§¸ÕÅç²Õ¦@36¤H¡A§Y©e°U²Ä¤T¤èÁ{§É¸ÕÅç ÅU°Ý¤½¥q¶i¦æ¤ÀªR¡A¨Ã´£¨Ñ¤ÀªR³ø§i¡A¥»¤½¥q¤w©ó2024/1/29¦¬¨ì³ø§i¡A¦¹³ø§i¹ï SNP-810¤§¬ãµo¼vÅT«¤j¡A¨ä«nµ²ªG¨Ì³W©w´¦ÅS¦p¤U¦C¦UÂI¡C ¤G¡B¸ÕÅçµû¦ô«ü¼Ð¡G ¥Dn«ü¼Ð¬°¨x«ü¼Æ¦å²M¾¢Ói»Ä¤þà¬Âà®ò°ò»Ã¯À(ALT)¿@«×®pÈ»P°ò¦Ȭۤñªº¦Ê¤À¤ñ ÅܤÆÈ¡C¦¸n«ü¼Ð¬°¬r©Ê¥NÁª«¤§¥Íª««ü¼ÐAAP-Cys adducts¤§®É¶¡¶¡¹j¥[Åv¦±½u¤U ±¿n(AUC)ªºÅܤơBALT®pȤɰª¤j©ó1~8¿¥¿±`ȤW¤ñ¨Ò¡BALT AUCªºÅܤƻPAAP¥NÁ ²£ª«AAP-Cys AUCªºÅܤƵ¥¡C ¤T¡B´¦¥Ü¥Dn¤Î¦¸nµû¦ô«ü¼Ð¤§²Îpµ²ªG¡G ®Ú¾Ú¤ÀªR³ø§iµ²ªGÅã¥Ü¡A¥Dn«ü¼Ð¡G¦U²ÕALT®pÈ»Pµ¹ÃÄ«e¤§°ò¦Ȭۤñ¤§¦Ê¤À¤ñµL ²Îp¤WÅãµÛ®t²§¡Aªí¥Ü¨Ï¥ÎSNP-810¨ä¤AñQÓi×ô¾¯¶q¨C¤Ñ4-8§J(¬°¹L¥h®Öã¤W¨C¤Ñ 4§Jªº2¿)§¡¥¼²£¥Í¨x¬r©Ê¡C¦¸n«ü¼Ð¡G¦U²Õ¦bALT®pȧ¡¥¼¶W¹L2¿¥¿±`È¡A§YALT ¤É°ª¤j©ó2~8¿¥¿±`ȤW¤§¤ñ¨Ò¬°0%¡C³Ì¥Dn¤ÏÀ³AAP¨x¬r©Ê¤§¬r©Ê¥NÁª«AAP-Cys adducts¤§AUCÅܤơBALT¤§AUCÅܤơA4-8§J¦U¾¯¶q²Õ¶¡§¡µL²Îp¤WÅãµÛ®t²§¡C¥NªíAAP ¸gglutathione¸Ñ¬r«á¤§¥NÁ²£ª«AAP-cys¤§AUC¦b8§J¾¯¶q²Õ¦³ÅãµÛªº¼W¥[¡A¦ý¤£¥Nªí ¬r©Ê¼W¥[¡C ¥|¡B¥»³ø§i«nµ²½×¡G ¨ü¸ÕªÌ¨Ï¥ÎSNP-810¨C¤é¾¯¶q4§J¡B4.5§J¡B5§J¡B6§J¤Î8§J§¡¥¼²£¥Í¨x¬r©Ê¡C (2)¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡B¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¥¼¹F²Îp¤W ÅãµÛ·N¸q©Îµo¥Í¨ä¥L¼vÅT·sÃĬãµo¤§«¤j¨Æ¥óªÌ¡A¤½¥q©Ò±Á{¤§·ÀI¤Î¦]À³±¹¬I¡G ¤£¾A¥Î (3)¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡B¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¹F²Îp¤W µÛ·N¸q©Îµo¥Í¨ä¥L¼vÅT·sÃĬãµo¤§«¤j¨Æ¥óªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G ¤£¾A¥Î (4)¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¦]¯A¤Î¥¼¨Ó°ê»Ú±ÂÅv½Í§P¸ê°T¡A¬°ÁקK¼vÅT±ÂÅvª÷ÃB¡A «O»Ù§ë¸ê¤HÅv¯q¡A¼È¤£´¦ÅS¡C 6.±N¦A¶i¦æ¤§¤U¤@¶¥¬q¬ãµo(½Ð»¡©ú¹wp§¹¦¨®É¶¡¤Î¹wpÀ³t¾á¤§¸q°È): (1)¹wp§¹¦¨®É¶¡¡G¹wpªñ´Á¤º§¹¦¨¡A¹ê»Ú®Éµ{»Ý¨Ì°õ¦æ¶i«×¶i¦æ¡C (2)¹wpÀ³t¾á¤§¸q°È¡G¤£¾A¥Î¡C 7.¥«³õ²{ªp: ®Ú¾ÚFuture Market Insights 2021¦~¥«³õ²Îp³ø§i«ü¥X¡A¥þ²yAcetaminophen (¤AñQÓi×ô)¤îµhÃÄ¥«³õ³W¼Ò©ó2020¦~¹ê»Ú¬ù¬°91.5»õ¬ü¤¸¡A¦Ó¥Dn¥«³õ¦p¥_¬ü ¦û¤ñ¬ù33.0%¡B¼Ú¬w¬ù26.3%©M¨È¬w(¥]§tªF¨È©M«n¨È°ê®a)¬ù31.7%¡CY¥H¨C¦~ ¦~§¡½Æ¦X¼Wªø²v(CAGR)4.1%pºâ¡A©ó2031¦~¥þ²y¤îµhÃÄ¥«³õ³W¼Ò¥i¹F140.7»õ ¬ü¤¸¡C°£¥»¤½¥qSNP-810(¦w®õ®³¯k)¥~¡A¥Ø«e¥«³õ¤W©|µL¨ä¥¦Ãþ¦üµL¨x¬r©Ê ¤AñQÓi×ô¤îµhÃÄÄvª§²£«~¡C 8.¨ä¥LÀ³±Ô©ú¨Æ¶µ(Y¨Æ¥óµo¥Í©Î¨Mij¤§¥DÅé«YÄݤ½¶}µo¦æ¥H¤W¤½¥q¡A ¥»«h«¤j°T®§¦P®É²Å¦XÃÒ¨é¥æ©öªk¬I¦æ²Ó«h²Ä7±ø²Ä8´Ú©Ò©w ¹ïªÑªFÅv¯q©ÎÃÒ¨é»ù®æ¦³«¤j¼vÅT¤§¨Æ¶µ): ³æ¤@Á{§É¸ÕÅçµ²ªG(¥]§t¥D¡B¦¸nµû¦ô«ü¼Ð¤§²Îp¾ÇPȤβÎp¾Ç¤W¬O§_¹FÅãµÛ·N¸q)¡A ¨Ã¤£¨¬¥H¥R¤À¤Ï¬M¥¼¨ÓÃÄ«~¶}µo¤W¥«¤§¦¨±Ñ¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C 9.·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C: |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/29 ¤U¤È 01:43:29
²Ä 3632 ½g¦^À³
|
¯uªº«Ü«ªº®D¼N·P~~~~~~¤£¯à¦A¦P·N¤F ¦n¦n¤@±iµP³Q¥´¦¨³o¼Ë¡A©Ô¤FJ³ÕI®Ñ?? ¥u¬O¦n©_¤jªÑªF¦b·F³Â¡A¤£¥h¬Ý°ê¨¾Âå·d¤°»ò ¤@°ï§ðÀ»±M§QÁÙ¬O¨¾¿m±M§Q ¤£µMªÑ»ù«e±¦hÓ1¡B2¡B3 ¦Ñ¸Ü¤@¥y¡AÁÙ¤£¦p¾Çªü³»¨ÓÄF¤@ªi¡CÁÙ¬O¦bÄFªº¸ô¤Wor¦ÄF§¹¤£ºt¤F ================================================ ¦³ºØ²ö¦Wªº®D¼N·P |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GStockMasterX10153259 |
µoªí®É¶¡:2024/1/24 ¤W¤È 11:34:52
²Ä 3631 ½g¦^À³
|
¦³ºØ²ö¦Wªº®D¼N·P¡A ·íªì¹ïªYÄ£¥Rº¡°ª«×´Á«Ý¡Aµ²ªG°£¤F¥u·|¬~¤@°ï¦U°ê±M§Q·s»D¥~.... ´N§¹¥þ¨S¥ô¦ó§@¬°¡A¨ì²{¦b°ß¤@ªZ¾¹I«áªºì²z¤]³vº¥³Q¦U¤½¥q¾Ç²ß¼Ò¥é¶W¶V¡AµM«áªYÄ£¤]§O¤H¨SÂá¡A ¨ººØ·Pı´N¹³¬O¤W¥j®É¥N¡A§O¤H³£ÁÙ¦b¥Î¥Û¾¹®É¡AªYÄ£²v¥ý°µ¥X¤p¤âºj¡A¦ý¬O¦]¬°»s§@¦¨¥»¤Ó°ª¡A ªYÄ£¤Sı±o¦Û¤v¬O¿W¥e¥«³õ¡A§è°ª®ð©ù¡AÁÙ¨ì³B¥h¦U°ê¥Ó½Ð±M§Q¡A·Q¬Ý½Ön¨Ó°ª»ù¸ò¥L̶R~ µ²ªG¦U°êªº¤H¤]¤£¬O²Â³J¡A¬Ý¨ì±M§Q¤º®e«á¡A¤j·§ª¾¹D¤è¦V¤F¡A´N¶¹L»s§@¤p¤âºjªº³¡¥÷¡A Á׶}±M§QªÈ¯Éªº¥i¯à©Ê¡Aµ²ªG¤Ï¦Ó³°Äò°µ¥X¾÷ºj¤õ¬¶....... µM«áªYÄ£ÁÙ¬Oı±o¤j®a·|§CÀY¸ò¥L¶R¡A¤S¤@ª½Ä~Äò¥Ó½Ð¨ä¥L°êªº¤p¤âºj±M§Q~ ¯uªºÆZ´d«sªº¡A´N¬O¤@ºØ·Q§¤¦a°_»ùªº·Pı¡AµM«á·à¤l¤j¶}¤f¡A¤H®aª½±µµLµø§A~ ¨ì³Ì«áªYÄ£n¦^ÀY§C»ù½æ±ÂÅv®É¡A¤H®a¤w¸g¬Ý¤£°_¤F~ ¦ý¬OªYÄ£¦b¦Û¤v°ê®a¤S¤£Ä@·N©Ó»{³o¨Æ¹ê¡A¬°¤F¤£Åý¤H¥Á¥¢±æ~ ¥u¦n¤@ª½¶R¦UºØ®ø®§¡AÅý¤j®aÁÙ¬O©ê¦³´Á«Ý~ ´N¦n¦ü·Å¤ôµN«Cµì~ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GWAHAHA10150571 |
µoªí®É¶¡:2024/1/23 ¤U¤È 07:58:55
²Ä 3630 ½g¦^À³
|
ªYÄ£¹ï¤â? Ävª§ªÌ?
¬üªÑ²§°Ê | ¤½§GªvÀøNASH¸ÕÅç¿n·¥µ²ªG Sagimet Biosciences(SGMT.US)º¦¶W170% ´¼³q°]¸g
Sagimet Biosciences(SGMT.US) 18.420 17.500 +170.09%
ºI¦Ü¦¬½L¡A¸ÓªÑº¦170.09%¡A³ø18.42¬ü¤¸
´¼³q°]¸gAPPÀò±x¡A¶g¤@¡ASagimet Biosciences(SGMT.US)ªÑ»ù©Ôº¦¡AºI¦Ü¦¬½L¡A¸ÓªÑº¦170.09%¡A³ø18.42¬ü¤¸¡A¦¨¥æ¶q¶W3611¸U¡C³o®a³B©óÁ{§É¶¥¬qªº¥Íª«»sÃĤ½¥q³ø§i¤F¨ä¥DnÔ¿ïÃĪ«denifanstat¦b¬Y¨Ç«D°sºë©Ê¯×ªÕ©Ê¨xª¢(NASH)ºC©Ê¨x¯f±wªÌ¤¤¶i¦æªº2b´Á¬ã¨sªº¿n·¥µ²ªG¡Cdenifanstat¦b2´Á©Î3´ÁÅÖºû¤Æªº¸g¬¡ÀËÃҹꪺNASH±wªÌ¤¤¡A¬Û¹ï©ó¦w¼¢¾¯¦b¬ã¨sªº¨âÓ¥Dn²×ÂI¤WÅã¥Ü¥X¤F²Îp¾Ç¤WªºÅãµÛ§ïµ½¡C
ȱoª`·Nªº¬O¡A©ó»´ä¤W¥«ªººq§¨îÃÄ-B(01672)¥»¤ëªì¤½§G¡A¨ä¥þ¸êªþÄݤ½¥q¥ÌµÜ»sÃĦ³¤½¥qªºÔ¿ïÃĪ«¥Òª¬¸¢¿E¯À¨üÅé£](THR£])¿E°Ê¾¯ASC41¤ù¥Î©óªvÀø¸g¨x¬ï¬¡ÀËÃҹꪺ«D°sºë©Ê¯×ªÕ©Ê¨xª¢(NASH)±wªÌªº52©PII´ÁÁ{§É¸ÕÅç¨ú±o¿n·¥´Á¤¤µ²ªG¡CASC41¨ã¦³¨xŦ¹v¦V©Ê©M°ª«×ªºTHR£]¿ï¾Ü©Ê¡C¤@¤éªA¥Î¤@¦¸ªºASC41¤ù¾¯¥Ñºq§±M¦³»s¾¯§Þ³N¶}µo¡CASC41¤ù¾¯»s¾¯±M§Q¤w¦b¬ü°êÀò±o±ÂÅv¡C
¥Ø«e¡A¬ü°ê¹«~©MÃĪ«ºÞ²z§½(FDA)©|¥¼§åã¥ô¦ó¥Î©óªvÀøNASHªºÃĪ«¡C¾Ú¦ôp¡A³oºØ¥Ñ¨xŦ¯×ªÕ°ï¿n¤Þ°_ªº¯e¯f¼vÅT¤F¤j¬ù1700¸U¬ü°ê¤H¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G½²ºû¤¯10143700 |
µoªí®É¶¡:2024/1/16 ¤U¤È 07:14:30
²Ä 3629 ½g¦^À³
|
810«D±MÄݱÂÅv¬O´¶¹MµL¬r¤Æºc·Q¡A¦U¤j¤pÃļtt¾á»´¡A³»¦h1©Î2»õ¬ü¤¸±ÂÅvª÷¡Fªp¥B¡A2¤jÃļt¤§«eÃã°h¨xª¢ÃıÂÅv®×¡AÀ³¬Ý¤W6¨tÃÄ»PªYÄ£Àq«´¤@©w¦³¡A¤~·|°µ¦¹Á«¤j¿ú¨M©w¡A«áÄò830¡B6¨t2ÁûÃĤ~¬O¥Dµæ¡Cþ¦³¥DµæÁÙ¨S¦Y¨ì´Np¸û¤pµæ¿úªº¡FÓ¤H¬O¼ÖÆ[¬Ý«Ý¡A¦ý§Æ±æ¦ÂIñӱÂÅv¨Óº²Â_º²Â_¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/13 ¤U¤È 09:02:07
²Ä 3628 ½g¦^À³
|
µý¾Ú«O¯d¦n¡A¤@§i¤@Ó·Ç¡A·d¤£¦n¤ñ±ÂÅvÁÙ¦nÁÈ¡C |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/13 ¤U¤È 08:35:21
²Ä 3627 ½g¦^À³
|
2023.3.7-ºqþ÷ºM¦^NASH药ª«¦b¬üII´Á试验¡A¨³´诉讼风ªi www.sohu.com/a/650587718_121029209 |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/13 ¤U¤È 08:17:54
²Ä 3626 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/30 ¤U¤È 06:03:59²Ä 2772 ½g¦^À³ èè¥XÄlªº²{¹ê®×¨Ò!
2022.12.30--Viking Therapeutics «ü±±¤¤°ê¤½¥qÅѨú¯×ªÕ¨xÃĪ«¾÷±K Vikingªí¥Ü¡A¥¦¦b°Q½×»P Ascletis ªº¦X§@®É¤À¨É¤F¦³Ãö¨äÃĪ«ªº¾÷±K«H®§ ...¥¦¦b 2019 ¦~°Q½×¡§¼ç¦b°Ó·~¾÷·|¡¨®É¦Vºq§´£¨Ñ¤F¦³Ãö¸ÓÃĪ«ªº¾÷±K«H®§¡C¾Ú Viking ºÙ¡Aºq§¦b¼f¬d¤F³o¨Ç«H®§«á¬ðµMµ²§ô¤F½Í§P¡Aºq§ªºº®u°õ¦æ©x¦¨¥ß¤F¤@®a©n©f¤½¥q Gannex Pharma¡A¶}©l¤Ó¤ë«á¶}µo¥X¤@ºØÄvª§©Ê NASH ªvÀø¤èªk¡C ----------------------------------------------------------------------------------------------------
¦Y¿}´N¯àªvÀø¨x¬rªº«H®§! |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/13 ¤U¤È 08:09:46
²Ä 3625 ½g¦^À³
|
2023.10.23--ªG¿}§@¬°¤@ºØ·s«¬Àç¾i«O°·«~¡A¥iªvÀø¹ï¤AñQ®ò°ò×ô (APAP) ¤Þ°_ªº¨x¬r©Ê www.oaepublish.com/articles/mtod.2023.28
Xin Tong (2023) 1Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48105, USA. 2Caswell Diabetes Institute, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
----------------------------------------------------------------------------------------------
Xin Tong (2014) GlaxoSmithKline, Clin Pharmacol Sci & Study Operat, Stevenage SG1 2NY, Herts, England
2023»P2014¬O¦P¤H??? |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/13 ¤U¤È 07:28:02
²Ä 3624 ½g¦^À³
|
³sR¤j³£¨SÀYºü¤F~~ ±Í¤H¬Ý¤F±M§Q«OÅ@½d³ò¡A¥[¤Wñªº¨óij¡A§Úı±o¬ð¯}½d³ò¬O¦³¥i¯à¡A¦ý¾÷²v¤£¤j¡C·íµM¥~°êªºRD½è¶q¸ê·½¤Ó¦h¡C ³Ñ¤Uªºµ{«rª÷¡A¥i¯à´N¬O¤j¼t¤@©ì®É¶¡¡A¬Ý½Ö¥ý¨ü¤£¤F¡C¥H©ì¦r³Z¡A©ì¨ì¤pģģ¨ü¤£¤F¤F |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/13 ¤U¤È 06:55:42
²Ä 3623 ½g¦^À³
|
¿ð¥¼Ã±¬ù±ÂÅv¡A¬O¤jÃļt¬ð¯}±M§Qº|¬}¦Û¤v¶}µoÁÙ¬Oµ{«rª÷¥X²{? §ÚÁÙ¯u¤£ª¾¹D!
2023.10.23--ªG¿}§@¬°¤@ºØ·s«¬Àç¾i«O°·«~¡A¥iªvÀø¹ï¤AñQ®ò°ò×ô (APAP) ¤Þ°_ªº¨x¬r©Ê www.oaepublish.com/articles/mtod.2023.28 ...µ²½×»P¥¼¨Ó¤è¦V ¤wµoªíªº¤u§@©M§Ú̪º¬ã¨s³£ªí©ú¡A²³©Ò©Pª¾ªº¡uÃa¿}¡vªG¿}¹ï¤AñQÓi×ô¤Þ°_ªº«æ©Ê¨x·l¶Ë¨ã¦³¹w¨¾©MªvÀø§@¥Î¡C§Ú̪ºµo²{¬O¬Û¹ïªì¨Bªº¡C»Ýn¨Ï¥Î¤HÃþ¨ü¸ÕªÌ¶i¦æ¶i¤@¨Bªº¬ã¨s¡A¥H«K«Ø¥ß¾A·í¥B¦³®ÄªºªvÀøp¹º¡C»P NAC ¬Û¤ñ¡AªG¿}¥i¯à³Qµø¬°¤@ºØ¼sªx¨Ï¥Îªº¸Ñ¬r¾¯... ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 08:57:53²Ä 926 ½g¦^À³ «ç»ò¶}©l¬y¦æ¦Y¿}ªvÀø¨x¬r???(ÁÙ¯u¦³®Ä!) ... ....±i¼w±j³Õ¤h»â¾Éªº¤@¶µ·s¬ã¨s¤¤¡C±K·²®Ú¤j¾ÇÂå¾Ç°|¤À¤l..¦b¤p¹«¤¤¡A¦b¹ï¤A酰®ò°ò×ô¹L¶q¤§«eµu®É¶¡¹¥Î°ªªG¿}¶¼¹¹ê»Ú¤W¥i¥H´£¨Ñ§Ü¨x·l¶Ëªº«OÅ@¡A¡¨ Yin»¡¡C¡§³o¯u¥O¤HÃø¥H¸m«H¡C¡¨ |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡Gdk10140377 |
µoªí®É¶¡:2024/1/13 ¤U¤È 05:08:44
²Ä 3622 ½g¦^À³
|
©Ò¥HG¦bJ«e±¥X¤â¤F¶Ü?µ¹¦h¤Ö¸uª÷©O
===================================== Ó¤Hµ²½×:nAPAP+Âù´âªâ»ÄÁp¦X¨Ï¥Î¡ASNP-810µL¨x¬r´N¬O°ß¤@¿ï¾Ü |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡GROGER588910148151 |
µoªí®É¶¡:2024/1/13 ¤W¤È 11:59:34
²Ä 3621 ½g¦^À³
|
first author:Vidhu Sethi Medical Affairs, Haleon (Formerly GSK Consumer Healthcare), GSK Asia House, Rochester Park, 139234, Singapore
2024.1.6-°ò©ó¼Ò«¬ªº¹ï¤AñQ®ò°ò×ôªº¨xŦ¦w¥þ©Êµû¦ô¡A¥H¤ä«ù¨ä»P¥~¥ÎÂù´âªâ»ÄÁp¦X¨Ï¥ÎªvÀø»´«×¦Ü¤¤«×°©Ãö¸`ª¢¯kµh link.springer.com/article/10.1007/s40122-023-00566-2 ¤fªA¹ï¤AñQ®ò°ò×ô©M¥~¥ÎÂù´âªâ»ÄªºÁp¦XªvÀø¨ã¦³¤¬¸Éªº§@¥Î¾÷¨î¡A¬O¼W±j°©Ãö¸`ª¢ (OA) ¯kµhÂíµh¤ÏÀ³ªº¤@ºØ¦³§l¤Þ¤Oªºµ¦²¤¡CÁöµM¥~¥ÎÂù´âªâ»Ä¦]¨ä¥þ¨¼ÉÅS¶q§C¦Ó³Q»{¬°¨ã¦³¨}¦nªº@¨ü©Ê¡A¦ý [¼Ð·ÇÂíµh¾¯¶q]¤U¹ï¤AñQ®ò°ò×ôªº¨x¬r©Ê°ÝÃD¤´µM¦s¦b¡C .....§Ú̪º¬ã¨s¤p²Õ´£¥X°²³]¨Ãªí©ú¡A»P¹ï¤AñQ®ò°ò×ô³æÃĪvÀøOA ¯kµh¬Û¤ñ¡A¤fªA¹ï¤AñQ®ò°ò×ô©M¥~¥ÎÂù´âªâ»ÄÁp¦XªvÀø«áªü¤ùÃþÃĪ«ªº¨Ï¥Î¶q·|´î¤Ö¡]¥¼µoªíªºµ²ªG¡^¡C¾¨ºÞ¦³³o¨Ç¥O¤H¹ª»Rªºµo²{¡A¦ý³oºØ²Õ¦X¦b OA ¤¤ªº¦w¥þ©Ê¤´¤£²M·¡¡C -------------------------------------------------------------------------------------------------
1.2020.2.17- FDA ®ÖãGSK §ß¥LªLÃö¸`ª¢¤îµhÃÄ(Âù´âªâ»Ä¶u§½³¡¾®½¦)¦b¬ü°ê§@¬°[«D³B¤è]ÃĨϥÎ-->²Ä¤@Ó¤]¬O°ß¤@¤@ ÓªvÀøÃö¸`ª¢¯kµhªº³B¤èÃÄ¥i¥H¥Î«D³B¤èÃľP°â 2. [¼Ð·ÇÂíµh¾¯¶q]¤U»P[ªø®É¶¡ªvÀø]ªº¹ï¤AñQ®ò°ò×ôªº¨x¬r©Ê°ÝÃD-->SNP-810µL¨x¬rÀòÃÒ¡A´N¤£¨ü[APAP¼Ð·ÇÂíµh¾¯¶q4g] »Pªø®É¶¡¨Ï¥Î¨î¡C Ó¤Hµ²½×:nAPAP+Âù´âªâ»ÄÁp¦X¨Ï¥Î¡ASNP-810µL¨x¬r´N¬O°ß¤@¿ï¾Ü |
|
¡@ |
¦^À³¥»¸ÜÃD
¦^¿³Âd°Q½×°Ï1¶ |
·|û¡G½²ºû¤¯10143700 |
µoªí®É¶¡:2024/1/11 ¤U¤È 07:21:14
²Ä 3620 ½g¦^À³
|
ªYÄ£¤½¥q¯à§Ö³t¶i®i¡B¦¨¥\¬O¥þÅé¤j¤pªÑªF´Á«Ý¡F´«Ó¨¤«×¬Ý¡A²{¦b«ù¦³ªYÄ£ªÑ²¼¨ä¹ê¬O¨S¦³À£¤Oªº¡A¦]¬°¥H¨äºD©Ê«O¦u¤ä¥X¡A7¦~¤º¤½¥q²{¦³²{ª÷¬O°÷ªº¡C7¦~«á©Ò¦³ªº8¨t¡B6¨t±ÂÅv¡A¬ð¯}¡B§Ö³q¸ê®æ§Q¦h¥i¯à¡B¤WÂd¥þ¹ê²{¡A¥|ÁûÃıÂÅvÁ`ª÷ÃB¹F0¡B35»õ¬ü¤¸¡A´NȲ{¦b70¤¸ªÑ»ù¡C©Ò¥H¡A¤j®a¦w¤ß«ù¦³ªÑ²¼§KÅå·|¤jÁȪº¡C |
|
¡@ |
¦^¿³Âd°Q½×°Ï1¶ |
³Ì·s100«h¦^ÂÐ >> |